Journal of the American College of Cardiology

Computerized community cholesterol control (4C)
pp. 263-263(1)
Authors: Gilutz H.; Zelingher J.; Henkin Y.; Bonneh D.Y.; Liss Z.; Peleg R.; Mayslus M.; Ilia R.; Porath A.

Activated monocytes induce smooth muscle cell apoptosis: role of the fasligand/fas death receptor pathway
pp. 263-263(1)
Authors: Vasudevan S.S.; Seshiah P.N.; Lopes N.; Wang T.; Dong C.; Goldschmidt-Clermont P.J.

IL-12 Mediated activation of cytotoxic CD4 T cells in acute coronary syndromes
pp. 263-263(1)
Authors: Nakajima T.; Abbas A.E.; Schultz S.; Warrington K.J.; Kopecky S.L.; Frye R.L.; Goronzy J.J.; Weyand C.M.

Monocyte chemotactic protein 1 amplifies serotonin-induced vascular smooth muscle cell proliferation
pp. 263-263(1)
Authors: Watanabe T.; Katagiri T.; Pakala R.; Benedict C.R.

MCP-1 Induces activation of map-kinases ERK, JNK, and p38 MAPK in human endothelial cells
pp. 263-264(2)
Authors: Werle M.; Hanna K.; Kreuzer J.

Production of MCP-1 by human aortic endothelial cells, upon depletion of nutrients, requires rac 1
pp. 264-264(1)
Authors: Lopes N.H.; Vasudevan S.S.; Kovacic H.; Goldschmidt-Clermont P.J.

Motexafin lutetium phototherapy induces apoptosis in macrophages and downregulates monocyte chemoattractant protein expression in human coronary artery smooth muscle cells
pp. 264-264(1)
Authors: Woodburn K.W.; Luo Y.; Sudhir K.

New classification of aortic dissection with improved impact on prognosis
pp. 264-264(1)
Authors: Richartz B.M.; Smith D.E.; Cooper J.V.; Mehta R.M.; Eagle K.A.; Nienaber C.A.

Familial aortic dissection/aneurysm associated with patent ductus arteriosus: a new entity?
pp. 264-264(1)
Authors: Van Kien P.K.; Lalande A.; Bonnet C.; Dellinger A.; Petit A.; Nivelon-Chevallier A.; Brunotte F.; Jeunemaitre X.; Wolf J.-E.

Comparison of medical treatment with percutaneous closure of patent foremen ovale for secondary prevention of TIAs and strokes: a case-control study
pp. 265-265(1)
Authors: Windecker S.; Wahl A.; Schwerzmann M.; Seiler C.; Nedeltchev K.; Arnold M.; Sturzenegger M.; Mattle H.; Meier B.

Effect of vitamin c on atherosclerosis progression and cardiovascular events in a ten-year randomized study (San Valentino)
pp. 265-265(1)
Authors: Nicolaides A.; Cesarone M.R.; Belcaro G.; De Sanctis M.; Incandela L.; Griffin M.

The ankle-brachial index: a predictor of cardiovascular mortality. the san valentino vascular screening study
pp. 265-265(1)
Authors: De Sanctis M.T.; Incandela L.; Cesarone M.R.; Bucci M.; Di Renzo A.; Griffin M.; Geroulakos G.; Sabetai M.; Nicolaides A.N.; Barsotti A.; Belcaro G.

Secular trends and long-term survival in thromboangiitis obliterans
pp. 265-265(1)
Authors: Tse T.-S.; McBane R.D.; Stanson A.W.; Ballman K.V.; Mikhail M.A.; Cooper L.T.

Activation of toll-like receptor 4 in adventitial cells by lipopolysaccharide induces neointima formation in a mouse model
pp. 265-265(1)
Authors: Vink A.; van der Meer J.J.; van Middelaar B.; Quax P.H.; Borst C.; Pasterkamp G.; de Kleijn D.P.

asociations of plasma vitamin D and Osteopotin levels with coronary artery calcification
pp. 266-266(1)
Authors: Momiyama Y.; Ohmori R.; Taniguchi H.; Nakamura H.; Ohsuzu F.

Quantitative dose-antithrombotic response of direct factor-Xa inhibitor ZK-807834 in stable coronary patients
pp. 266-266(1)
Authors: Zaiar M.U.; Farkouh M.E.; Osende J.; Shimbo D.; Palencia S.; Fuster V.; Chesebro J.H.

Acute systemic inflammation enhances tissue plasminogen activator release in man
pp. 266-266(1)
Authors: Chla S.; Reid K.S.; Dawson P.; Ludlam C.A.; Fox K.A.; Newby D.E.

ACE inhibition and tissue plasminogen activator release in patients with heart failure
pp. 266-266(1)
Authors: Witherow F.N.; Ludlam C.A.; Fox K.A.; Newby D.E.

Relationship of plasma von Willebrand factor with stroke risk factors in 1,321 patients with Atrial Fibrillation
pp. 266-266(1)
Authors: Conway D.S.; Pearce L.A.; Chin B.S.; Hart R.G.; Lip G.

In-vivo measurement of coronary Angiotension-Converting Enzyme (ACE) activity in humans
pp. 267-267(1)
Authors: Staniloae C.; Gallo R.; Dyrda I.; Gosselin G.; Lesperance J.; Ryan J.W.; Schwab A.J.; Simard A.; Dupuis J.

BNP preserves endothelial cell integrity: modulation by atherosclerosis and vasopeptidase inhibition
pp. 267-267(1)
Authors: Larsen A.M.; Sandberg S.M.; Leskinen H.; Cataliotti A.; Burnett J.C.

Characteristics of coronary resistance artery function in a biracial cohort with severe left ventricular hypertrophy
pp. 267-267(1)
Authors: Houghton J.L.; Torosoff M.T.

Effect of acute atrial fibrillation on coronary circulation
pp. 267-267(1)
Authors: Vardas P.E.; Kochiadakis G.E.; Skalidis E.I.; Igoumenidis N.E.; Kaleboubas M.D.; Vardakis K.E.; Chrysostomakis S.I.; Hamilos M.I.

Central pulse pressure and proximal aortic stiffness remain unchanged during the normal human menstrual cycle
pp. 268-268(1)
Authors: Skeli N.O.; Mitchell G.F.; Solomon C.G.; Seely E.W.

Weight loss does not alter sympatheticatly-mediated vascular tone in normotensive obese humans
pp. 268-268(1)
Authors: Agapitov A.V.; Correia M.L.; Dopp J.M.; Sinkey C.A.; Phillips B.G.; Haynes W.G.

Determinants of coronary artery compliance in subjects with and without angiographic coronary artery disease
pp. 268-268(1)
Authors: Shaw J.A.; Walton A.S.; Kingwell B.A.; Cameron J.D.; Dart A.M.

Obesity is associated with increased condult vessel stiffness in a community-based cohort: the NHLBI framingham heart study
pp. 268-268(1)
Authors: Mitchell G.F.; Benjamin E.J.; Kupka M.J.; Larson M.G.; Levy D.

Slow flow on distal left anterior descending coronary artery demonstrated by transthoracic doppler echocardiography predicts pathologic coronary flow dynamics
pp. 268-269(2)
Authors: Youn H.-J.; Jeon H.-K.; Cho E.-J.; Oh Y.-S.; Chung W.-S.; Kim J.-H.; Choi K.-B.; Hong S.-J.

Long-Term prognostic value of triiodothyronine concentration in elderly patients with stable heart failure
pp. 269-269(1)
Authors: Rays J.; Wajngarten M.; Gebara O.E.; Nussbacher A.; Batista J.; Azul S.; Pierri H.

The predictive value of combinations of different levels of brain natriuretic peptide and norepinephrine in the Val-HeFT trial
pp. 269-269(1)
Authors: Anand I.S.; Latini R.; Masson S.; Judd D.; Maggioni A.P.; Glazer R.; Chiang T.; Lechat P.; Tognoni G.; Cohn J.N.

N-Terminal pro brain natriuretic peptide (NT-proBNP) predicts left ventricular function and mortality in hemodialysis patients but not cardiac death: a two-year outcome study
pp. 269-269(1)
Authors: Longhitano J.P.; Henrich W.L.; Light P.D.; Tiblier E.; Sperger H.; Smiley M.M.; Badalamenti J.; Trawinski J.; deFilippi C.R.

Effect of combined hormone replacement therapy on thrombotic and fibrinolytic potentials and Lp(a) levels in elderly women
pp. 269-269(1)
Authors: Gebara O.C.; Venturinell M.; Aldrighi J.M.; Vieira N.; Nussbacher A.; Pierri H.; Joao S.-A.; D'Amico E.; Wajngarten M.; Rosano G.; Ramires J.A.

eta-Adrenergic inhibition of leptin production is attenuated in obese individuals
pp. 270-270(1)
Authors: Dopo J.M.; Agapitov A.V.; Haynes W.G.; Sinkey C.A.; Somers V.K.; Phillips B.G.

Difference of high-sensitive C-reactive protein levels in patients treated with statins, aspirin, and angiotensin II modulators
pp. 270-270(1)
Authors: Takeda T.; Hoshida S.; Suna S.; Taniike M.; Egami Y.; Shutta R.; Kawabata M.; Nishino M.; Tanahashi H.; Tanouchi J.; Yamada Y.

Folic acid supplementation substantially reduces hyperhomocysteinemia induced by fenofibrate
pp. 270-270(1)
Authors: Melenovsky V.; Stulo T.; Grauova B.; Wichterle D.; Kozich V.; Kriji J.; Haas T.; Ceska R.

Secretory phospholipase is related to other coronary heart disease risk factors
pp. 270-270(1)
Authors: Mobassori S.; Tangney C.C.; Lu L.; Rosenson R.S.

Predictors of 13-Year changes in the total cholesterol to high-density lipoprotein cholesterol ratio
pp. 270-271(2)
Authors: Scranton R.E.; Sesso H.D.; Glynn R.J.; Gaziano J.M.

Cholesterol screening of adults in the US: role of socio-demographic factors
pp. 271-271(1)
Authors: Bartalos C.R.; Sun C.; Marinac J.S.

Contemporary awareness and understanding of cholesterol as a risk factor: results of an American Heart Association national survey
pp. 271-271(1)
Authors: Nash I.S.; Mosca L.; Blumenthal R.S.; Davidson M.; Smith S.C.

Lowering LDL cholesterol with simvastatin, an HMG-CoA reductase inhibitor, does not affect luteal function in women
pp. 271-271(1)
Authors: Santoro N.; Plotkin D.; Mitchel Y.; Waldstreicher J.; Liu M.

Lack of association of celecoxib with an increased risk of thromboembolic events
pp. 271-271(1)
Authors: Faich G.; Allen I.E.; Ross S.D.; Lefkowith J.B.

Ominous prognostic implications and inadequacy of heparin alone for right heart thrombi in patients with acute pulmonary embolism: analysis of baseline characteristics, echocardiograms, treatment, and clinical outcomes in the International Cooperative Pulmonary Embolism Registry
pp. 271-272(2)
Authors: Torbicki A.; Goldhaber S.Z.; Galie N.; Covezzoli A.; De Rosa M.

Comparison of narrow versus standard target INR ranges
pp. 272-272(1)
Authors: Meier D.J.; Sonnad S.S.; Merz J.C.; Fay W.P.

Alteplase improves the clinical course of patients with major pulmonary embolism: a multicenter, randomized, placebo-controlled trial (management strategies and prognosis in pulmonary embolism study 3)
pp. 272-272(1)
Authors: Konstantinides S.; Geibel A.; Kasper W.

The association between inflammatory markers and thrombogenic factors in postinfarction patients
pp. 272-272(1)
Authors: Harb T.S.; Zareba W.; Moss A.J.; Ridker P.M.; Ritai N.; Marder V.J.; Miller-Watelet L.

C-reactive protein predicts microalbuminuria
pp. 272-272(1)
Authors: Messerli A.W.; Sachar R.; Pearce G.L.; Hoogwerf B.J.; Sprecher D.L.

Role of acute phase reactants and infection as predictors for major adverse clinical events and angina pectoris after percutaneous coronary intervention
pp. 273-273(1)
Authors: Rahel B.M.; Diepersloot R.J.; de Jongh B.M.; Visseren F.; Kelder J.C.; Suttorp M.-J.; Plokker T.W.

No impact of statin treatment on integrin expression on leucocytes in patients with stable coronary artery disease
pp. 273-273(1)
Authors: Friedrich J.; Siegler K.M.; Anders C.; Gok R.; Klein B.; Winkler R.; Weise S.; Kunkler A.; Taubert G.; Senges J.

Increased C-reactive protein levels in women at increased cardiovascular risk predict one-year events only when associated with increased interleukin-6 levels
pp. 273-273(1)
Authors: Rosano G.M.; Gebara O.; Mercuro G.; Sarais C.; Saiu F.; Ramires J.F.; Fini M.

Endothelial microparticles correlate with high-risk angiographic lesions in acute coronary syndromes
pp. 273-273(1)
Authors: Bernal-Mizrachi L.; Fierro C.; McDonough E.; Purow J.; Jy W.; Velasquez H.S.; Jimenez J.J.; Horstman L.L.; Ahn Y.S.; Marchena E.

Association of Trp64arg 3-adrenergic receptor gene polymorphism with LDL particle size in Japanese population
pp. 274-274(1)
Authors: Okumura K.; Matsui H.; Imai H.; Mizuno T.; Imamura A.; Ogawa Y.; Kamiya H.

LDL particle concentration and insulin level predict carotid atheroeclerosis in high risk patients
pp. 274-274(1)
Authors: Post W.S.; Blumenthal R.S.; Yanek L.R.; Moy T.F.; Becker L.C.; Becker D.M.

Prevalence of atherogenic LDL pattern B in asymptomatic middle aged African Americans with a family history of premature coronary heart diseases
pp. 274-274(1)
Authors: Nasir K.; Becker D.M.; Yanek L.R.; Moy T.F.; Becker L.C.; Blumenthal R.S.

Yellow coronary plaques observed with angioscopy are closely related to increased plasma levels of triglyceride-rich remnant lipoproteins
pp. 274-274(1)
Authors: Kondo N.; ueda Y.; Kurotobi T.; Shimizu M.; Otani T.; Hirayama A.; Kodama K.

Extremely high levels of lipoprotein(a) [Lp(a)] are associated with peripheral endothelial dysfunction in a multiethnic cohort
pp. 274-275(2)
Authors: Wu H.D.; Berglund L.; Dimayuga C.; Jones J.; Sciacca R.; Di Tullio M.R.; Homma S.

Age and lipoprotein(a) are independent predictors of coronary but not aortic arteriosclerosis on electron beam tomography
pp. 275-275(1)
Authors: Raggi P.; Friede G.; Plourd D.; Boyer J.L.

The influence of hypertension on management and outcome of acute coronary syndrome
pp. 275-275(1)
Authors: Majahalme S.K.; Smith D.E.; Cooper J.V.; Kline-Rogers E.M.; Almanaseer Y.; Akhras E.; Mehta R.H.; Eagle K.A.; Bisognano J.D.

Influence of hypertension on the initial and long-term outcome of patients treated with coronary stenting
pp. 275-275(1)
Authors: Alonso J.J.; Gimeno F.; Ramos B.; Duran J.M.; Munoz J.C.; Fuente L.; Pastor G.; Gomez I.; Bermejo J.; Fernandez-Aviles F.

Elevated pulse pressure on admission after acute myocardial infarction reduces short- and long-term all-cause and cardiac mortality: an analysis of survival trials
pp. 275-275(1)
Authors: Yee Guan Yap; Duong T.; Bland M.; Malik M.; Torp-Pederson C.; Kober L.; Marchant B.; Camm A.J.

Impaired coronary flow reserve determines left ventricular diastolic dysfunction in arterial hypertension
pp. 275-276(2)
Authors: Zeidan Z.; Yang Y.; Bartel T.; Ebralidze T.; Buck T.; Eggebrecht H.; Erbel R.

Left atrial remodeling associated with diastolic dysfunction: a population-based study
pp. 276-276(1)
Authors: Pritchatt A.M.; Mahoney D.W.; Rodeheffer R.J.; Jacobsen S.J.; Redfield M.M.

Transthoracic doppler harmonic echocardiography detects microvascular dysfunction in patients with arterial hypertension
pp. 276-276(1)
Authors: Bartel T.; Yang Y.; Muller S.; Eggebrecht H.; Erbel R.

Effects of a selective COX-2 inhibitor (MF-tryciclic) on atherosclerosis progression as well as on mouse cytomegalovirus replication in ApoE knockout mice
pp. 276-276(1)
Authors: Rott D.; Zhu J.; Burnett M.S.; Yi Fu Zhou; Ganley A.; Ogunmakinwa J.; Epstein S.E.

Influenza infection exerts prominent inflammatory and thrombotic effects on atherosclerotic plaques of apo E- deficient mice
pp. 276-277(2)
Authors: Litovsky S.; Wyde P.; Madjid M.; Akhtar A.; Naguib S.; Siadaty S.; Sanati S.; Casscells W.; Naghavi M.

Acute chlamydia pneumoniae infection causes diffuse coronary endothelial dysfunction in pigs
pp. 277-277(1)
Authors: Liuba P.; Pesonen E.; Paakkari I.; Forslid A.; Sandstrom S.

Antibodies to chlamydial heat shock protein 60 is associated with coronary artery disease but antibodies to human heat shock protein 60 and escherichia coli homologs are not
pp. 277-277(1)
Authors: Mahdi O.S.M.; Horne B.D.; Muellen K.; Muhlestein J.B.; Byrne G.I.

Chronic but not acute perivascular infection with chlamydia pneumoniae resulted in plaque pormation in vivo
pp. 277-277(1)
Authors: Engelmann M.G.; Redl C.V.; Pellsek J.; Barz C.; Heesemann J.; Nikol S.

Adenosine deaminase inhibition attenuates the inflammatory response to sepsis and improves survival
pp. 277-277(1)
Authors: Hollenberg S.M.; Cohen E.S.; Cruz K.Q.; Nardulli B.; Law W.R.; Parrillo J.E.

Metallothionein elicits second window of myocardial protection in rabbit hearts through mitogen-activated protein kinase mechanism
pp. 278-278(1)
Authors: Chen K.; Zhang J.; Li D.; Mehta J.L.

Matrix metalloproteinase inhibition attenuates postinfarction left ventricular remodeling
pp. 278-278(1)
Authors: Mankad S.; Peterson J.T.; Teekell-Taylor L.; Magovern J.A.; Biederman R.W.W.; Rogers W.J.; Ripple J.; Yamrozik J.; Reichek N.

Phosphatidylinositol 3-kinase/AKT pathway contributes to ischemic preconditioning in isolated rabbit heart
pp. 278-278(1)
Authors: Jlao Z.; Gorodnya O.M.; Downey J.M.; Fan T.-H.M.

Endocardial cyrotheraphy induces marked arterlogenesis in normal porcine myocardium
pp. 278-278(1)
Authors: Gallo R.; Chauvet P.; Urick M.; Burke A.; Virmani R.

Adenosine administered from the beginning of reperfusion protected myocardial stunning by activation of A1 receptors and K+ATP channels
pp. 278-278(1)
Authors: Donato M.; D'Annunzio V.; Morales C.; Saban M.; Scapin O.; Gelpi R.J.

Nitroglycerin reduces blood viscosity: a novel mechanism to explain the enhancement of nutrient blood flow to ischemic zones
pp. 279-279(1)
Authors: Bin J.-P.; Leong-Poi H.; Fisher N.G.; Takalkar A.M.; Wei K.; Kaul S.

Prehospital fibrinolysis: is it safe, feasible, and efficient in a large urban north american center?
pp. 279-279(1)
Authors: Welsh R.C.; Travers A.; Sosnowski T.; Williams R.; Senaratne M.; Lakhani Z.; Armstrong P.W.

A randomized study to investigate the hemostatic effect of tenecteplase (TNK-t-PA) versus alteplase (rt-PA) and streptokinase (SK) in acute myocardial infarction
pp. 279-279(1)
Authors: Andreotti F.; Biasucci L.M.; Berioli S.; Crespi G.; De Marco E.; Porto A.; Albiero D.; Maseri A.; Rebuzzi A.G.

Comparison of the frequency and outcomes of investigator assessed recurrent mi versus Clinical Event Committee (CEC) adjudicated recurrent mi in acute MI trials: a TIMI 14 and TIMI 9 substudy
pp. 279-279(1)
Authors: Murphy S.A.; Giugliano R.P.; Wong G.; Cannon C.P.; Antman E.M.; Gibson M.

Is recurrent myocardial infarction following thrombolytic administration associated with long-term mortality?
pp. 280-280(1)
Authors: Gibson M.; Murphy S.A.; James D.; Wong G.; Cannon C.P.; Glugliano R.P.; Antman E.M.; Braunwald E.

International differences in patients, care, and outcomes associated with acute myocardial infarction: the hero-2 trial
pp. 280-280(1)
Authors: Simes J.; White H.D.; Marschner I.C.; Varshavsky S.; Diaz R.; Wilcox R.G.; Armstrong P.W.; Granger C.B.; French J.K.; Van de Werf F.; Aylward P.E.

Coronary artery passivation: a mechanism for the prevention of recurrent ischemia after thrombolysis
pp. 280-280(1)
Authors: Rubenstein M.H.; Garabedian H.D.; Guerrero L.; Sullivan S.M.; Aretz T.; Virmani R.; Hollenbach S.; Leinbach R.C.; Gold H.K.

Impact of enoxaparin and abcixlmab on bleeding complications in acute myocardial infarction: insights from assent-3
pp. 280-280(1)
Authors: Dens J.; Fioretti P.M.; Lopez-Sendon J.L.; Verheugt F.; Meyer J.; Toutouzas P.; Wallentin L.; Granger C.; Armstrong P.; Van de Werf F.J.

Collaborative Angiographic Patency Trial of Recombinant Staphylokinase (CAPTORS II)
pp. 281-281(1)
Authors: Armstrong P.W.; Burton J.; Molhoek P.G.; Betriu A.; Tendera M.; Bode C.; Bar F.; Adgey J.; Vahanian A.; Van de Werfs F.

Intravenous adenosine diphosphate P2T platelet receptor antagonism as an adjunct to fibrinolysis for acute myocardial infarction
pp. 281-281(1)
Authors: Greenbaum A.B.; Ohman E.M.; Gibson M.S.; Borzak S.L.; LeMay M.; Lu M.; Stebbins A.L.; Emanuelsson H.; Weavers W.D.

Aging of intracoronary thrombus due to delayed time-to-reperfusionsincreases ischemic and angiographic complications in acute myocardial infarction
pp. 281-281(1)
Authors: Giri S.; Gibson M.; Eisenhauer A.C.; Kuntz R.E.; Rogers C.; Murphy S.; Mitchel J.; Antman E.M.; Simon D.I.

Magnesium reduces free radicals generated by direct current shocks and prevents left ventricular dysfunction in an in vivo swine model
pp. 281-281(1)
Authors: Zhang Y.; Davies L.R.; Martin S.M.; Buettner G.R.; Kerber R.E.

Superior outcome with immediate manual defibrillation versus automated external defibrillation in a swine model of prehospital ventricular fibrillation cardiac arrest
pp. 282-282(1)
Authors: Xavier L.C.; Berg R.; Hilwig R.; Kern K.B.; Sanders A.; Ewy G.A.

Flight attendant response to AED instruction: results of a survey and implications for training public access defibrillation
pp. 282-282(1)
Authors: Takata T.S.; Kowal R.C.; Joglar J.A.; Hamdan M.H.; Nguyen C.L.; Li J.-M.; Phan N.H.; Kizilbash A.M.; Campbell L.A.; McKenas D.K.; Page R.L.

Cardiac troponin I predicts mortality pediatric out-of-hospitals cardiopulmonary arrest
pp. 282-282(1)
Authors: Checchia P.A.; Moynihan J.; Daher N.; Sehra R.

Defibrillation threshold and cardiac function using an external biphasic defibrillator in pediatric-sized pigs
pp. 282-282(1)
Authors: Killingsworth C.R.; Walcott G.P.; Melnick S.B.; Chapman F.W.; Walker R.G.; Smith W.M.; Idekers R.E.

Survival of myocardial infarction patients treated with aspirin is enhanced by prehospital administration
pp. 282-282(1)
Authors: Barbash I.M.; Freimark D.; Gottlieb S.; Hod H.; Battler A.; Hasin Y.; Crystal E.; Boyko V.; Behar S.; Leor J.

Early defibrillation training courses for lay volunteers without cardiopulmonary resuscitation education: the piacenza progetto vita experience
pp. 283-283(1)
Authors: Capucci A.; Aschieri D.; Piepoli M.; Rosi A.; Bonibaldoni E.; Saltarelti M.; Arvedi M.

The Scal atrial natriuretic peptide gene polymorphism in relation to nonfatal myocardial infarction in patients with angiographically confirmed coronary heart disease
pp. 283-283(1)
Authors: Gruchala M.; Ciecwierz D.; Dubaniewicz W.; Wasag B.; Targonski R.; Ochman K.; Dworakowski R.; Sobiczewski W.; Curyllo B.; Rynkiewicz A.

Connexin40 mRNA and protein expression is elevated in end-stage human ischemic heart disease
pp. 283-283(1)
Authors: Kaba R.A.; Dupont E.; Matsushita T.; Coppen S.R.; Yacoub M.H.; Severs N.J.

Circulating bone marrow cells differentiate into cardiomyocytes in infarcted heart
pp. 283-283(1)
Author: Kuramochi Y.

A brief episode of myocardial ischemia in the rat turns on novel sets of genes
pp. 283-283(1)
Authors: Simkhovich B.Z.; Marjoram P.; Dow J.; Kedes L.; Kloner R.A.

Gene polymorphisms of TNF-b and IL-6, but not TNF-a, are associated with the inflammatory response in ischemic heart disease
pp. 284-284(1)
Authors: Biasucci L.M.; Liuzzo G.; Stranieri C.; Santamaria M.; Angiolillo D.J.; Rizzello V.; Di Gianuario G.; Ginnetti F.; Porto A.; Pignatti P.

The 894G T polymorphism in the endothelial nitric oxide synthase gene influences risk for acute myocardial infarction only in subjects with low risk for coronary events
pp. 284-284(1)
Authors: Andrikopoulos G.K.; Richter D.; Grammatopoulos D.; Zervou S.; Zairis M.; Karabinos E.; Pantazis A.; Manolatos D.; Exadaktylos N.; Stefanadis C.; Foussas S.; Gialafos J.; Hillhouse E.; Toutouzas P.

Continuing evolution of treatment strategy and outcome for coronary artery disease: observational data 1986-2000
pp. 284-284(1)
Authors: Smith P.K.; Lilly E.R.; Tuttle R.H.; Shaw L.K.; Lee K.L.; Peterson E.D.; Sketch M.H.; Jones R.H.

Symptomatology and presenting electrocardiogarm change with age in acute coronary syndromes
pp. 284-284(1)
Authors: Stern S.; Behar S.; Boyko V.; Leor J.; Gottlieb S.

Degree of resolution of baseline ST-segment depression predicts better outcome in patients with non-ST-segment elevation acute coronary syndrome
pp. 285-285(1)
Authors: Timoteo A.T.; Ferreira J.; Aguiar C.; Almeida M.; Ribeiro M.A.; Seabra-Gomes R.

Joint effects of preinfarction angina and development of collateral vessels on outcome in patients with acute myocardial infarction who underwent primary coronary intervention
pp. 285-285(1)
Authors: Kinio K.; Sato H.; Sato H.; Shiotani I.; Ohnishi Y.; Nakatani D.; Mizuno H.; Hishida E.; Kinoshita N.; Fujii K.; Hori M.

Impaired endothelial function and oxidative modification of LDL are not related to the severity of coronary atherosclerosis
pp. 285-285(1)
Authors: Koulouris S.; Karabinos I.; Kranidis A.; Melpidou A.; Stefanakis F.; Kardara D.; Papageorgakis N.; Karahalios T.; Exadaktylos N.; Kardaras F.

Increased expression of adrenomedullin in Directional Coronary Atherectomy (DCA) specimens in patients wth unstable angina
pp. 285-285(1)
Authors: Ishikawa T.; Hatakeyama K.; Imamura T.; Ito K.; Hara S.; Date H.; Koiwaya Y.; Shibata Y.; Hikichi Y.; Asada Y.; Eto T.

Thrombus embolization as a cause of acute myocardial infarction: its frequency and implication of treatment
pp. 285-285(1)
Authors: Asano K.; Ito H.; Kawano S.; Iwakura K.; Katoh A.; Ikushima M.; Tanaka K.; Inoue Y.; Kuroda T.; Okamura A.; Fujii K.

Increased serum levels of macrophage migration inhibitory factor-related protein is a sensitive marker for acute coronary syndrome in patients with coronary artery disease
pp. 286-286(1)
Authors: Miyamoto S.; Ikemoto M.; Hasegawa K.; Nagaya N.; Tamaki S.-i.; Miwa K.; Fujita M.

A randomized comparison of the effects of clopidogrel and aspirin on thrombotic variables and C-reactive protein following myocardial infarction
pp. 286-286(1)
Authors: Woodward M.; Lowe G.D.; Francis L.M.; Rumley A.; Cobbe S.

Too little aspirin for secondary prevention in high risk patients
pp. 286-286(1)
Authors: Frilling B.; Schiele R.; Gitt A.K.; Schneider S.; Zahn R.; Senges J.

Lower myocardial infarction risk from selective serotonin reuptake inhibitors but not other antidepressants
pp. 286-286(1)
Authors: Sauer W.H.; Berlin J.A.; Kimmel S.E.

Effects of zoloft(R) on platelet/endothelial biomarkers in depressed patients after acute coronary events: Sertraline Anti-Depressant Heart Attack Randomized Trial (SADHART platelet substudy)
pp. 286-287(2)
Authors: Serebruany V.; Glassman A.; Malinin A.; Krishnan R.; Finkel M.; Nemeroff C.; Gurbel P.; Clary C.; Harrison W.; O'Connor C.

The association of isosorbide-5-monitrate to an ACE inhibitor started early after myocardial infarction improves left ventricular structure and function over three months: the Delapril and Remodelling in Acute Myocardial Infarction (DRAMI) study
pp. 287-287(1)
Authors: Latini R.; Maggioni A.P.; Staszewsky L.; Labarta V.; Marino P.; Cremonesi G.; Gramenzi S.; Sarcina G.; Piras S.

Stroke reduction with low-medium dose warfarin/ aspirin combination following myocardial infarction in the CHAMP study
pp. 287-287(1)
Authors: Plehn J.F.; Shintani A.K.; Ezekowitz M.D.; Peduzzi P.N.; Rahko P.S.; Fiore L.D.

Female gender does not impact outcomes in patients with postinfarct left ventricular dysfunction treated with carvedilol
pp. 287-287(1)
Authors: Remme W.J.; Dargie H.J.; Ford I.; Sendon J.-L.L.; Sharpe N.; Blank A.

Effects of losartan and quinapril on myocardial infarct size and endothelial function
pp. 287-287(1)
Authors: Zhu B.; Sievers R.E.; Browne A.E.; Lee R.J.; Chattejee K.; Grossman W.; Parmley W.W.

Does losartan benefit endothelial dysfunction and experimental infarct size in rats exposed to second hand smoke?
pp. 288-288(1)
Authors: Zhu B.; Slevers R.E.; Browne A.E.; Hillman R.T.; Chair K.; Lee R.J.; Chatterjee K.; Grossman W.; Glantz S.A.; Parmley W.W.

Activation of Caspase-3 in the remodeling heart after myocardial infarction is prevented by treatment with ramiprilate
pp. 288-288(1)
Authors: Schwarz K.; Simonis G.; Lux M.; Strasser R.H.

Early administration of losartan induces unfavorable evolution of postinfarct remodeling in rabbits
pp. 288-288(1)
Authors: Gonzalez G.E.; Morales C.; Rodriguez M.; Mangas F.; Palleiro J.; Gelpi R.J.

Simultaneous activation of both cardiac angiotensin formation and degradation in the acute phase of myocardial infarction
pp. 288-288(1)
Authors: Boddi M.; Coppo M.; Papa M.L.; Cecioni I.; Polidori G.; Marchionni N.; Modesti P.A.; Serneri G.G.N.

ACE inhibitors and angiotensin II receptor antagonists independently but synergistically increase coronary blood flow and attenuates the severity of contractile and metabolic dysfunction in ischemic hearts
pp. 288-288(1)
Authors: Kitakaze M.; Node K.; Takashima S.; Minamino T.; Asanuma H.; Asakura M.; Kim J.; Sanada S.; Ogita H.; Asano Y.; Shintani Y.; Hori M.

Disparate clinical outcomes of diabetic and nondiabetic patients undergoing primary angioplasty for acute myocardial infarction: is diabetes mellitus an independent predictor of poor outcome?
pp. 289-289(1)
Authors: Hariai K.J.; Grines C.L.; Pham T.; Stone G.W.; Chandra H.; Boura J.; Mattos L.; Cox D.; Grines L.L.; O'Neill W.W.

Does abciximab and stenting improve outcomes in elderly patients undergoing primary PCI for acute myocardial infarction: data from the CADILLAC trial
pp. 289-289(1)
Authors: Guagliumi G.; Cox D.A.; Grines C.; Garcia E.; Stuckey T.; Tcheng J.; Pasquini J.; Carroll J.; Lansky A.; Stone G.W.

Excessive hospital mortality of ST elevation myocardial infarction in female diabetics: results of the MITRA and MIR registries
pp. 289-289(1)
Authors: Gitt A.K.; Schiele R.; Wienbergen H.; Heer T.; Meisenzahl C.; Gottwik M.G.; Senges J.

Does gender independently influence the treatment and outcomes of patients with early reinfarction after fibrinolysis?
pp. 289-289(1)
Authors: Tjandrawidjaja M.C.; Fu Y.; Van de Werf F.; Granger C.B.; Armstrong P.W.

Reperfusion therapy with either intravenous thrombolysis or primary PTCA in elderly patients is beneficial: one-year results from a nationwide French registry of acute myocardial infarction
pp. 290-290(1)
Authors: Danchin N.; Vaur L.; Genes N.; Ferrieres J.; Angioi M.; Etienne S.; Cambou J.-P.

Gender is an independent predictor of both in-hospital and one-year outcomes following primary intervention for acute myocardial infarction
pp. 290-290(1)
Authors: Skelding K.A.; Harjai K.; Mehta L.; Stone G.W.; Cox D.A.; Boura J.A.; Grines L.L.; O'Neill W.W.; Grines C.L.

Outcomes for Asian Indians following acute ST elevation myocardial infarction: results from the GUSTO trials
pp. 290-290(1)
Authors: Menon V.; She L.; Arshad R.; Hellkamp A.S.; Rao S.V.; Hochman J.S.; Ohman E.M.

Predicting and preventing myocardial infarction with clopidogrel in patients with symptomatic atherothrombosis: results from CAPRIE
pp. 290-290(1)
Author: Cannon C.P.

Ramipril prevents major cardiovascular events in high-risk women: results of the HOPE trial
pp. 290-291(2)
Authors: Lonn E.; Roccaforte R.; Yi Q.; Bosch J.; Probstfield J.; Sleight P.; Dagenais G.; Yusuf S.

Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk diabetic patients
pp. 291-291(1)
Authors: Lonn E.; Gerstein H.; Pogue J.; Yi Q.; Hoogwerf B.J.; Bosch J.; Dagenais G.; Yusuf S.

Pharmacodynamic interactions between tadalafil and nitrates
pp. 291-291(1)
Authors: Kloner R.; Emmick J.; Bedding A.; Humen D.

Randomized comparison of exercise training versus PTCA/stent in stable coronary artery disease: effects on clinical status and maximal exercise capacity
pp. 291-291(1)
Authors: Conradi K.; Mobius-Winkler S.; Walther C.; Sick P.; Yu J.; Kenziorra K.; Kluge R.; Hambrecht R.; Schuler G.

Assessment of reperfusion therapy on regional and global left ventricular function in patients with chronic total coronary artery occlusions
pp. 291-291(1)
Authors: Ermis C.; Boz A.; Tholakanahalli V.; Yalcinkaya S.; Semiz E.; Sancaktar O.; Miller L.W.; Deger N.; Benditt D.G.

Nitric oxide activity in complex atheromatous plaques
pp. 291-292(2)
Authors: Tousoulie D.; Tentolouris C.; Crake T.; Toutouzas C.; Trikas A.; Pitsavos C.; Stefanadis C.; Davies G.; Toutouzas P.

Selective serotonin 5HT_2A receptor inhibition attenuates myocardial ischemia through the increase in nitric oxide production: the alternative role of 5HT_1B receptor
pp. 292-292(1)
Authors: Sanada S.; Kitakaze M.; Node K.; Asanuma H.; Ogita H.; Takashima S.; Asakura M.; Minamino T.; Hori M.

Left ventricular filling and remodeling after myocardial infarction: results from the GISSI-3 echo substudy
pp. 292-292(1)
Authors: Temporelli P.L.; Giannuzzi P.; Gentile F.; Lucci D.; Maggioni A.P.; Nicolosi G.L.

Beneficial effect of revascularization in elderly patients with cardiogenic shock
pp. 292-292(1)
Authors: Kugelmass A.; Sadanandan S.; Tarkington L.G.; Battaglia S.L.; Simon A.W.; Culler S.D.; Becker E.R.

Improving outcome in treatment of diabetics with ST elevation myocardial infarction: insights from the GUSTO trials
pp. 292-292(1)
Authors: Gurm H.S.; Tang W.H.W.; Lee D.; Jia G.; Lincoff A.M.; Topol E.J.

Demographic parameters predict strongly all-cause and arrhythmic mortality in high risk patients after myocardial infarction in the thrombolytic era: a secondary analysis of survival trials
pp. 293-293(1)
Authors: Yap Y.G.; Duong T.; Bland M.; Malik M.; Torp-Pederson C.; Kober L.; Connolly S.; Marchant B.; Camm A.J.

Assessment of international differences in 30-day event of death and reinfarction amongst patients with acute coronary syndromes: insights from GUSTO IV ACS
pp. 293-293(1)
Authors: Midodzi W.K.; Chang W.-C.; Fu Y.; Boersma E.; Cooper J.; Barnathan E.; Simoons M.L.; Wallentin L.; Ohman E.M.; Armstrong P.W.

Should CK-MB measurements be abandoned in acute coronary syndrome patients
pp. 293-293(1)
Authors: Yee K.C.; Smith D.E.; Kline-Rogers E.M.; Almanaseer Y.; Akhras E.; Cooper J.V.; Mehta R.H.; Eagle K.A.

Early identification of myocardial infarction in the emergency department by a change in serum myoglobin
pp. 293-293(1)
Authors: Sallach S.M.; Sallach J.A.; Hudson M.P.; McCord J.

Improved outcome of acute ST-segment elevation myocardial infarction in patients with prior coronary artery bypass surgery treated with combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition
pp. 293-294(2)
Authors: Mukherjee D.; Gurm H.; Tang W.H.W.; Roffi M.; Wolski K.; Moliterno D.J.; Guetta V.; Ardissino D.; Bode C.; Steg G.; Lincoff A.M.; Topol E.J.

Early and late survival following primary PTCA for acute myocardial infarction in patients with saphenous vein graft occlusion
pp. 294-294(1)
Authors: Brodle B.R.; Stuckey T.; Hansen C.; Muncy D.; VerSteeg D.; Pulsipher M.; Gupta N.

Clinical and angiographic predictors of abnormal doppler-derived flow in the infarct related artery after primary angioplasty for acute myocardial infarction
pp. 294-294(1)
Authors: Dixon S.R.; O'Neill W.W.; Fry J.A.; Safian R.D.; Goldstein J.A.; Grines C.L.; Bowers T.R.

Corrected Timi Frame Count (CTFC) and quantitative stress myocardial perfusion imaging defect score independently predict major adverse cardiac events following successful primary angioplasty: a dipyridamole Tc99m sestamibi gated SPECT imaging study
pp. 294-294(1)
Authors: Giri S.; Ahlberg A.; Mitchel J.; Gibson M.; Alkelyani A.; Popma J.J.; Katon D.; Eisenhauer A.C.; Heller G.V.

Role of abciximab in the preservation of myocardial microcirculation during mechanical reperfusion for acute ST segment elevation myocardial infarction
pp. 294-295(2)
Authors: Mulumudi M.S.; Potluri S.P.; White C.J.

Comparative prognostic value of myocardial blush grade and TIMI frame count for clinical outcome after acute myocardial infarction
pp. 295-295(1)
Authors: Haager P.K.; Christoti J.P.; Lepper W.; Janssens U.; Hoffmann R.

Intraaortic balloon pumping can preserve microvascular integrity and myocardial viability in patients with reperfused anterior acute myocardial infarction
pp. 295-295(1)
Authors: Huang X.; Liu Y.; Wu P.; Chen X.; Zhang J.; Zha D.

Contribution of microvascular dysfunction to impaired flow in the noninfarct related artery: observations during primary intervention and following intracoronary nitroprusside
pp. 295-295(1)
Authors: Lee S.T.; Miele N.J.; Sharaf B.L.; Williams D.O.

Beneficial effects of brain natriuretic peptide in acute myocardial ischemia
pp. 295-295(1)
Authors: Khankirawatana B.; Khankirawatana S.; Lof J.; Porter T.

Clinical outcome of patients with acute myocardial infarction randomized to either coronary stenting plus abciximab or fibrinolysis plus abciximab (STOPAMI-2 Trial)
pp. 295-296(2)
Authors: Schoemig A.; Kastrati A.; Mehilli J.; Dirschinger J.; Schricke U.; Neverve J.; Pache J.; Martinoff S.; Neumann F.-J.; Nekolla S.; Blasini R.; Seyfarth M.; Schwaiger M.

Upregulation of anglotensin subtype receptor 1 (AT1) and beta adrenergic receptor (Beta 1-AR) and downregulation of AT2, transforming growth factor beta 1 (TGF-Beta 1), and TGF-Beta receptor II in intimal hyperplasia of intramyocardial coronary arteries distal to a severe epicardial coronary stenosis
pp. 296-296(1)
Authors: Hong H.; Aksenov S.; Guan X.; Xiao G.; Talleyrand A.; Waters D.; Fallon J.T.; Chen C.

Impaired coronary collateral vessel recruitment in diabetes mellitus: evidence for defective ischemic tolerance
pp. 296-296(1)
Authors: Nisanci Y.; Sezer M.; Umman B.; Umman S.; Oflaz H.; Yilmaz E.; Erzengin F.; Ozsaruhan O.

Frequency and determinants of silent plaque disruption in patients with stable coronary syndrome
pp. 296-296(1)
Authors: Sun Y.; Ma S.; Mizuno K.; Takano M.; Seimiya K.; Okamatsu K.; Kamon H.; Uemura R.; Ishibashi F.; Yokoyama S.; Ohba T.

Homocysteine and coagulation factors as a risk factor of myocardial infarction at a young age
pp. 296-296(1)
Authors: Saigo M.; Abe S.; Ogawa M.; Biro S.; Minagoe S.; Yamashita T.; Matsuoka T.; Torii H.; Toda H.; Atsuchi Y.; Mawatari K.; Maruyama I.; Tei C.

Subsets of CD8+ T cells are expanded in stable coronary artery disease
pp. 297-297(1)
Authors: Jonasson L.; Wikby A.; Tompa A.

Six-month prognosis of patients diagnosed with myocardial infarction by World Health Organization criteria versus New European Society Cardiology/ American College Cardiology troponin-based criteria
pp. 297-297(1)
Authors: Trevelyan J.; Lencioni M.; Gieowarsingh S.; Needham E.W.; Smith S.C.; Mattu R.K.

Impact of new diagnostic criteria for myocardial infarction in an unselected United Kingdom cohort with suspected cardiac chest pain
pp. 297-297(1)
Authors: Trevelyan J.; Gieowarsingh S.; Lencioni M.; Needham E.W.; Smith S.C.; Mattu R.K.

Validation of ACC-AHA 2000 guidelines for the risk stratification of patients with non-ST elevation acute coronary syndromes
pp. 297-297(1)
Authors: Bazzino O.; Botto F.; Estrada J.N.; Liprandi M.I.S.; Fuselli J.J.; Santopinto J.; Ahuad R.; Nordaby R.; Salzsberg S.; Prado A.H.; Lopez J.; Russo M.; Perez M.; Bruno C.; De Miguel R.

A simple risk score for prediction of 30-day mortality in patients with acute coronary syndrome: insights from GUSTO IV
pp. 297-298(2)
Authors: Tang W.H.W.; Gurm H.S.; Piedmonte M.; Barnathan E.S.; Cooper J.; Califf R.M.; Topol E.J.

One-year follow-up of mortality in the GUSTO IV trial evaluating the effects of 24 - 48 hours abciximab infusion in noninvasively managed acute coronary syndrome patients
pp. 298-298(1)
Authors: Simoons M.; Armstrong P.; Barnathane E.; Califf R.; James S.; Topol E.; Wallentin L.

Clinical benefits of Glucose-Insulin-Potassium infusion in coronary artery bypass grafting: is improved diastolic function the mechanism?
pp. 298-298(1)
Authors: Tsang M.W.; Davidoff R.; Hesselvik J.F.; Nguyen H.; Shapira O.M.

Is vitamin C superior to diltiazem for radial artery vasodilation in patients awaiting coronary artery bypass grafting? A randomized double blind study
pp. 298-298(1)
Authors: Drossos G.E.; Toumpoulis I.K.; Katritsis D.G.; Ioannidis J.P.; Kontoglorgi P.; Svarna E.; Siminelakis S.; Anagnostopoulos C.E.

Quality of life of patients with symptomatic multivessel coronary disease: the medicine, angioplasty, or surgery study (MASS II)
pp. 299-299(1)
Authors: Carrara D.; Hiscock S.B.; Margarido E.S.; Tanaka A.; Takiuti M.E.; Favarato D.; Luz P.L.; Hueb W.; Olveira S.A.; Ramires J.A.

Predictors of stroke after conventional versus coronary revascularization without cardiopulmonary bypass
pp. 299-299(1)
Authors: Stamou S.C.; Pfister A.J.; Jablonski K.A.; Hill P.C.; Dullum M.K.; Bati A.S.; Boyce S.W.; Petro K.; Corso P.J.

Use of both internal mammary arteries for coronary artery bypass grafting in diabetics avoiding median sternotomy
pp. 299-299(1)
Authors: Guijelmos V.; Kappert U.; Schneider J.; Cichon R.; Nicolai J.; Diegeler A.

Cardioprotection caused by ischemic preconditioning or by an alpha 1-adrenergic receptor agonist is blocked in hearts from epsilon protein kinase C knockout mice
pp. 299-299(1)
Authors: Zhou H.-z.; Karliner J.S.; Zhu P.; Mochly-Rosen D.; Messing R.O.; Gray M.O.

A new development of high fidelity canine DNA microarray: application for the assessment of gene expressions of reversibly or irreversibly injured ischemic myocardium
pp. 299-300(2)
Authors: Asakura M.; Kitakaze M.; Sanada S.; Asanuma H.; Takashima S.; Minamino T.; Node K.; Ogita H.; Asano Y.; Shintani Y.; Yulin L.; Hori M.

Reduction of myocardial infarct size by a HMG CoA-reductase inhibitor in normocholesterolemic rats
pp. 300-300(1)
Authors: Wolfrum S.; Grimm M.; Heidbreder M.; Dendorter A.; Katus H.A.; Liao J.K.; Richardt G.

Simvastatin restores endothelial nitric oxide mediated vasorelaxation in large arteries after myocardial infarction
pp. 300-300(1)
Authors: Bates K.; Goldman S.; Gaballa M.

Inhibitory effects of the novel antagonist of both GP IIb/IIIa and vitronectin receptors on the formation of coronary thromboemboli caused by an inhibition of adenosine receptors during coronary hypoperfusion in dogs
pp. 300-300(1)
Authors: Asanuma H.; Kitakaze M.; Node K.; Sanada S.; Ogita H.; Takashima S.; Asakura M.; Minamino T.; Tada M.; Hori M.

Early microvascular reflow status after infarct reperfusion determines outcome of postinfarction remodeling independent of myocardial salvage
pp. 300-300(1)
Authors: Bowen F.; Moainie S.L.; Gorman J.H.; Salgo I.; Guy T.S.; St. John-Sutton M.; Edmunds L.H.; Gorman R.C.

Impaired healing in factor XIII KO mice after myocardial infarction assessed by magnetic resonance imaging
pp. 300-301(2)
Authors: Nahrendorf M.; Hu K.; Hiller K.-H.; Waller C.; Gattenlohner S.; Dickneite G.; Haase A.; Bauer W.R.; Ertl G.

Ventricular-arterial coupling in nondilated chronic heart failure following coronary artery ligation in mice
pp. 301-301(1)
Authors: Voltchikhina S.A.; Yacono B.C.; Cheng L.; Lakatta E.G.; Talan M.I.

Correlation between ST resolution and angiographic findings in ST elevation myocardial infarction
pp. 301-301(1)
Authors: Sabatine M.S.; Morrow D.A.; Heidbuchel H.; de Lemos J.A.; Vlassak S.; Cooper H.A.; Schuhwerk K.C.; Murphy S.A.; McCabe C.H.; Giugliano R.P.; Antman E.M.; Gibson M.; Braunwald E.; Van de Werf F.

Predictive value of 60-minute ST segment resolution in electrocardiogram after lytic therapy in patients with acute myocardial infarction: results from the GUSTO V-RESTART study
pp. 301-301(1)
Authors: Cura F.A.; Roffi M.; Pasca N.; Wolski K.E.; Topol E.J.; Lauer M.S.

Comparison of TIMI myocardial perfusion grade with coronary flow reserve for prediction of recovery of LV function and LV remodeling in acute myocardial infarction
pp. 301-301(1)
Authors: Choi S.-Y.; Tahk S.-J.; Lian Z.-X.; Yoon M.-H.; Lim H.-S.; Cho I.-H.; Choi T.-Y.; Chang H.-J.; Hwang G.-S.; Shin J.-H.; Kim H.-S.; Choi B.-i.W.

An angiographic risk score integrating both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute MI
pp. 302-302(1)
Authors: Gibson M.; Murphy S.A.; Marble S.J.; Gourlay S.P.; Gibbons R.; Barron H.V.

Myocardial perfusion in patients with non-ST-segment elevation acute coronary syndrome assessed with venous contrast echocardiography
pp. 302-302(1)
Authors: Firschke C.; Zielinska M.; Martinoff S.; Andrassy P.; Schwaiger M.; Schomig A.

Significant myocardial salvage in patients with non-ST elevation myocardial infarction is common: results using serial myocardial perfusion imaging
pp. 302-302(1)
Authors: Kontos M.C.; Kurdziel K.A.; Ornato J.P.; Jesse R.L.; Tatum J.L.

Old age and myocardial infarct size in the reperfusion era
pp. 302-302(1)
Authors: Kloner R.A.; Poole K.; Shook T.; Przyklenk K.; Perritt K.

Rarity of circumflex culprits in ST-elevation MI is due to relative ECG silence
pp. 302-302(1)
Authors: Nguyen T.T.; Dixon S.R.; Fry J.A.; O'Neill W.W.; Grines C.L.; Goldstein J.A.

Does prior angina predict outcomes following acute myocardial infarction? Testing the relevance of ischemic pre-conditioning in the era of primary angioplasty
pp. 302-303(2)
Authors: Harjai K.J.; Grines C.L.; Sadeghi H.M.; Ledford C.; Marsalese D.; Boura J.; Safian R.D.; Goldstein J.A.; Kahn J.; O'Neill W.W.

Characteristics and outcome of patients with ST elevation versus non-ST elevation myocardial infarction: results of the MONICA Augsburg Myocardial Infarction Registry 1985-1995
pp. 303-303(1)
Authors: Kuch B.; Bolte H.D.; von Scheidt W.; Lowel H.

Opportunities for enhancing the use of evidence-based medicines for acute coronary syndromes: insights from the SYMPHONY studies
pp. 303-303(1)
Authors: Kramer J.; Newby L.K.; Simes J.; Van de Werf F.; Granger C.; Lee K.; Bhapkar M.; Califf R.; Armstrong P.W.

Early use of glycoprotein 2b3a inhibitors and outcomes in non-ST elevation MI: observations from the NRMI-4
pp. 303-303(1)
Authors: Peterson E.D.; Canto J.G.; Pollack C.V.; Parsons L.; Roe M.T.; Littrell K.; Every N.R.; Barron H.V.

Comparison of characteristics, treatment, and outcomes of patients enrolled versus not enrolled in a clinical trial: findings from TIMI 9 Registry and 9b trial
pp. 303-303(1)
Authors: Bahit M.C.; Antman E.M.; Murphy S.A.; McCabe C.H.; Cannon C.P.

Approach after thrombolytic therapy: invasive versus conservative management: global registry of acute coronary events
pp. 303-304(2)
Authors: Sadig I.; Dauerman H.L.; Goldberg R.J.; Klein W.; Brieger D.; Steg P.G.; Montalescot G.; Lopez-Sendon J.; Budaj A.; Gore J.M.

Elevated white blood cell count is associated with higher mortality in patients with acute coronary syndromes independent of other cardiac markers: a TACTICS - TIMI 18 Substudy
pp. 304-304(1)
Authors: Sabatine M.S.; Morrow D.A.; Murphy S.A.; Demopoulos L.A.; DiBattiste P.M.; McCabe C.H.; Cannon C.P.; Braunwald E.; Gibson M.

Elevated C Reactive Protein (CRP) is associated with a higher risk of thrombotic occlusion and poorer flow following percutaneous coronary intervention in patients with acute coronary syndromes: a TACTICS TIMI 18 angiographic substudy
pp. 304-304(1)
Authors: Gibson M.; Morrow D.; Vicari R.; Wong G.; Demopolous L.; DiBattiste P.; Murphy S.A.; Cannon C.P.; Braunwald E.

Effect of atorvastatin on C-reactive protein in patients with acute coronary syndromes: a substudy of the MIRACL trial
pp. 304-304(1)
Authors: Kinlav S.; Rifai N.; Libby P.; Ganz P.

Detection of cardiac neurohormonal activation complements cardiac troponin for predicting recurrent events in UA/NSTEMI: prognostic utility of BNP in TACTICS-TIMI 18
pp. 304-305(2)
Authors: Morrow D.A.; de Lemos J.A.; Sabatine M.S.; Murphy S.A.; DiBattiste P.M.; McCabe C.H.; Cannon C.P.; Braunwald E.

The inter-relationship between creatinine clearance, cardiac troponin T and outcomes in patients with acute coronary syndromes
pp. 305-305(1)
Authors: Aviles R.J.; Askari A.T.; Ohman E.M.; Mahaffy K.W.; Newby L.K.; Berger P.; Jia G.; Califf R.M.; Lindahl B.; Wallentin L.; Topol E.J.; Lauer M.S.

Elevated serum myoglobin is associated with increased long-term mortality, independent of cardiac troponin I, electrocardiographic variables, and other baseline variables: combined analyses from TIMI 11B and TACTICS/TIMI 18
pp. 305-305(1)
Authors: de Lemos J.A.; Morrow D.A.; Gibson M.; Murphy S.A.; Rifai N.; Sabatine M.S.; Cooper H.A.; McCabe C.H.; Antman E.M.; Cannon C.P.; Braunwald E.

Prevention of reinfarction using half-dose reteplase and abciximab: observation from the GUSTO-5 trial
pp. 305-306(2)
Authors: Ohman E.M.; Califf R.M.; Lincoff M.; Armstrong P.; Kleiman N.; Hochman J.; White H.; Savonitto S.; Piedmonte M.; Booth J.; Topol E.J.

The Abciximab ST-Recovery on AMI (ASTRONAMI) GUSTO V substudy: enhanced early speed, stability, and quality of reperfusion with anti-pletelet augmented thrombolytic therapy for ST-elevation AMI
pp. 306-306(1)
Authors: Krucoff M.W.; Green C.L.; Langer A.; Gibler B.; Armstrong P.W.; Trollinger K.M.; Crater S.W.; Lincoff M.A.; Califf R.M.; Topol E.J.

Combination tenecteplase and abciximab results in more complete ST resolution: findings from the ASSENT 3 ECG substudy
pp. 306-306(1)
Authors: Fu Y.; Wagner G.; Goodman S.; Van de Werf F.; Granger C.B.; Armstrong P.W.

Differential impact of antithrombotic treatments combined with tenectoplase in the elderly with acute myocardial infarction: results from ASSENT-3
pp. 306-306(1)
Authors: Granger C.B.; Alexander J.H.; Lesaffre E.; Wallentin L.; Armstrong P.W.; Van de Werf F.

Lack of improvement in ST segment resolution after the combination treatment of abciximab with reteplase compared to reteplase alone for acute myocardial infarction: results from the GUSTO V-RESTART substudy
pp. 306-306(1)
Authors: Cura F.A.; Roffi M.; Pasca N.; Wolski K.E.; Topol E.J.; Lauer M.S.

Risk and benefit of half-dose lytic plus abciximab versus lytic alone for ST-elevation myocardial infarction: a meta-analysis
pp. 306-307(2)
Author: Verheugt F.W.

Multiple plaque ruptures in patients with acute myocardial infarction: an angioscopic evidence of systemic cause of plaque instability
pp. 307-307(1)
Authors: Fujimori Y.; Morio H.; Terasawa K.; Shiga T.; Hatano M.; Osegawa M.; Uchida Y.; Morita T.

Natural history of multiple complex coronary plaques in patients with acute myocardial infarction: a study with coronary angiography
pp. 307-307(1)
Authors: Lee S.-G.; Cheol Whan Lee; Hong M.-K.; Park S.-W.; Park S.-J.

Snow removal as a trigger of sudden cardiac death in men of higher socioeconomic status
pp. 307-307(1)
Authors: Chowdhury P.S.; Franklin B.A.; Boura J.A.; Dragovic L.J.; Kanluen S.; Spitz W.; Hodak J.; O'Neill W.W.

Multifocal plaque instability correlates with elevated C-reactive protein
pp. 307-307(1)
Authors: Chandra H.R.; Raff G.; Fry J.; Dixon S.; O'Neill W.W.; Goldstein J.A.

Prevalence of intimal CRP in unstable angina atheroma: modification by statin therapy
pp. 308-308(1)
Authors: Bauriedel G.; Andrie R.; Skowasch D.; Braun P.; Schiele T.M.; Luderitz B.

Enhanced expression of lectin-like oxidized low density lipoprotein receptor (LOX-1) at sites of the culprit lesion in patients with acute coronary syndromes
pp. 308-308(1)
Authors: Sakanoue Y.; Naruko T.; Haze K.; Otsuka M.; Itoh A.; Ogami M.; Ikura Y.; Ohsawa M.; Ueda M.

Carotid atherosclerotic plaque instability in patients with acute myocardial infarction
pp. 308-308(1)
Authors: Rossi A.; Franceschini L.; Fusaro M.; Golia G.; Zardini P.

Early and late results of thrombectomy prior to stenting in acute myocardial infarction: principal report of the EndiCOR X-SIZER AMI registry
pp. 308-308(1)
Authors: Cox D.A.; Stuckey T.; Babb J.; Low R.; Cannon L.; Iwaoka R.; Turco M.; Brodie B.; Lansky A.; Stone G.W.

Stenting in acute myocardial infarction: restenosis is primarily caused by stent underexpansion
pp. 308-308(1)
Authors: Schaefer A.; Fischer D.; Meyer G.P.; Klein G.; Lippolt P.; Hausmann D.

Long-term outcome in patients with acute myocardial infarction undergoing primary percutaneous intervention: a pooled analysis of the primary angioplasty in myocardial infarction trials
pp. 309-309(1)
Authors: Ledford C.S.; Grines C.L.; Stone G.W.; Cox D.; Brodie B.; Grines L.; Boura J.; O'Neill W.W.

Have the outcomes of rescue angioplasty after failed thrombolytic therapy in acute myocardial infarction improved in the stent era?
pp. 309-309(1)
Authors: Adamian M.G.; Stone G.W.; Mehran R.; Dangas G.; Abizaid A.S.; Abizaid A.; Mohamed M.; Adamyan Y.; Reyes A.; Hjazi I.; Iakovou I.; Hirose M.; Lansky A.J.; Moses J.W.; Leon M.B.

Stenting in acute myocardial infarction in patients with chronic renal failure: predictors of in-hospital and long-term outcome
pp. 309-309(1)
Authors: Adamian M.G.; Mehran R.; Dangas G.; Farkhou M.; Abizaid A.; Reyes A.; Hjazi I.; Negoita M.; Mohamed M.; Cioara C.; Pop R.; Lansky A.J.; Stone G.W.; Moses J.W.; Leon M.B.

Poor one year prognosis in acute myocardial infarction patients with saphenous vein grafts as the infarct related vessel treated by primary balloon angioplasty
pp. 309-309(1)
Authors: Nguyen T.T.; O'Neill W.W.; Dixon S.R.; Boura J.A.; Grines L.; Cox D.A.; Stone G.W.; Brodie B.; Grines C.L.

Effect of treatment with platetet glycoprotein IIb/IIIa inhibitors on in-hospital outcomes of patients treated with primary angioplasty for acute myocardial infarction
pp. 309-310(2)
Authors: Vakili B.A.; Slater J.N.; Sherman W.; Ravi K.L.; Green S.J.; Sanborn T.A.; Brown D.L.

TENAX-XR a:SIC-H coated stent versus noncoated stents in 485 patients with acute coronary syndrome: 9- and 18-month follow-up: the TRUST trial
pp. 310-310(1)
Author: Hamm C.

807CC genotype of the platelet Gp Ia could represent a protective factor for recurrences of acute coronary events in acute coronary syndromes
pp. 310-310(1)
Authors: Leone A.M.; Casorelli I.; Burzotta F.; Paciaroni K.; Sciahbasi A.; De Stefano V.; Leone G.; Andreotti F.; Maseri A.

Heparin/PF4 complex antibodies in patients with unstable angina: evaluation of cardiac thrombotic events in 24 months of follow-up
pp. 310-310(1)
Authors: Mattioli A.V.; Fontanesi L.; Bonetti L.; Vandelli R.; Mattioli G.

Risk of ischemic events can be predicted by angioscopic evaluation of yellow plaques
pp. 310-310(1)
Authors: Ohtani T.; Ueda Y.; Shimizu M.; Kondou N.; Hirayama A.; Kodama K.

Acute myocardial infarction in HIV-infected patients
pp. 310-311(2)
Authors: Matetzky S.; Daar E.; Domingo M.; Cercek B.

Impact of reocclusion on six-year survival and reinfarction following fibrinolytic therapy: long-term follow-up of the apricot-1 trial
pp. 311-311(1)
Authors: Kievit P.C.; Brouwer M.A.; Meijer A.; Veen G.; Verheugt F.W.A.

Resting heart rate as a predictive risk factor for sudden death in the population
pp. 311-311(1)
Authors: Jouven X.X.; Zureik M.; Sabbah L.; Courbon D.; Desnos M.; Guerot C.; Ducimetiere P.

Does troponin positivity add prognostic value to quantitative ST segment depression in predicting death and myocardial infarction in non-ST elevation acute coronary syndrome patients?
pp. 311-311(1)
Authors: Kaul P.; Fu Y.; Newby L.K.; Mahaffey K.W.; Harrington R.A.; Ohman E.M.; Van de Werf F.; Armstrong P.W.

Repetitive brief myocardial ischemia and reperfusion induces a cardiomyopathy with features of myocardial hibernation in mice: a possible role for chemokines
pp. 311-312(2)
Authors: Dewald O.; Frangogiannis N.G.; Zoerlein M.; Knuefermann P.; Pham T.T.; Taffet G.; Michael L.H.; Entman M.L.

Serum levels of unbound free fatty acids reveal high sensitivity for early detection of acute myocardial infarction in patient samples from the TIMI II trial
pp. 312-312(1)
Authors: Kleinfeld A.M.; Kleinfeld K.J.; Adams J.E.

A cardioprotective agent, JTV519, inhibits apoptotic cell death of postischemic reperfused myocardium through _PKC-mediated ERK activation
pp. 312-312(1)
Authors: Takenaka H.; Kihara Y.; Inagaki K.; Yoneda T.

Hearts of stat 6 knockout mice are resistant to ischemia reperfusion injury
pp. 312-312(1)
Authors: Yamaura G.; Fukuda S.; Kishima K.; Cui J.; Engelman R.M.; Das D.K.

Glucagon-Like Peptide-1 (GLP-1) limits myocardial stunning following acute coronary occlusion and reperfusion in conscious canines
pp. 312-312(1)
Authors: Nikolaidis L.A.; Hentosz T.; Doverspike A.; Huerbin R.; Zourelias L.; Stolarski C.; Elahl D.; Shannon R.P.

Cardiac serum marker release after percutaneous transluminal septel myocardial ablation: a human model
pp. 312-313(2)
Authors: Gum P.A.; Steinhubl S.R.; Lever H.M.; Van Lente F.; Tuzcu E.M.; Lincoff A.M.

Nonwhite race is associated with a higher rate of death and ischemic complications in patients with acute coronary syndromes despite modern early invasive treatment
pp. 313-313(1)
Authors: Sabatine M.S.; Blake G.J.; Drazner M.H.; Morrow D.A.; Demopoulos L.A.; DiBattiste P.M.; McCabe C.H.; Cannon C.P.; Braunwald E.

HIV disease and acute coronary syndromes
pp. 313-313(1)
Authors: Gould R.B.; Pearlstein N.B.; De Voe M.C.; Coppola J.T.; Siegal P.P.; Ambrose J.A.

Benefit of invasive strategy for women with acute coronary syndromes: observations from the TACTICS-TIMI 18 trial
pp. 313-313(1)
Authors: Glaser R.; Herrmann H.C.; Murphy S.A.; Demopoulos L.A.; DiBattiste P.M.; Cannon C.P.; Braunwald E.

Dramatic increase in 30-day mortality in diabetic patients with non-ST segment elevation acute coronary syndromes
pp. 313-314(2)
Authors: Roffi M.; Cho L.; Bhatt D.L.; White J.A.; Molitemo D.J.; Harrington R.A.; Topol E.J.

In-hospital outcome of acute myocardial infarction in patients with prior coronary artery bypass surgery: a study from NRMI 3
pp. 314-314(1)
Authors: Mathew V.; Gersh B.J.; Barron H.; Every N.; Tiefenbrunn A.; Frederick P.; Malmgren J.

Cardiovascular manifestations of carbon monoxide poisoning
pp. 314-314(1)
Authors: Satran D.; Henry C.R.; Chaney C.I.; Adkinson C.D.; Henry T.D.

Outcome after acute myocardial infarction in young patients: analysis of the PAMI database
pp. 314-314(1)
Authors: Corpus R.A.; Boura J.A.; Stone G.W.; Brodie B.R.; Cox D.A.; Garcia E.; Grines L.L.; O'Neill W.W.; Grines C.L.

Interleukin-1 beta predicts death or myocardial infarction independently of high-sensitivity C-reactive protein and standard risk factors in patients with coronary artery disease
pp. 314-315(2)
Authors: Lappe J.M.; Muhlestein J.B.; Carlquist J.F.; Davis B.P.; Horne B.D.; Anderson J.L.

The combination of troponin and CRP levels at admission: a strong prognostic indicator of one-year mortality in both men and women with unstable coronary artery disease
pp. 315-315(1)
Authors: James S.K.; Armstrong P.; Califf R.; Siegbahn A.; Simoons M.; Wallentin L.

Low HDL cholesterol is a strong independent risk marker in non-ST segment elevation acute coronary syndromes
pp. 315-315(1)
Authors: Fuselli J.J.; Guetta J.N.; Boissonnet C.P.; Godia J.; Tattamanzi A.; Quiroga S.; Torres V.

Clinical utility of myocardial perfusion imaging in patients presenting with chest pain to the emergency room
pp. 315-315(1)
Authors: Shivalkar B.; Rinkevich D.; Kaul S.; Ghaemmaghami C.; Belcik T.; Wel K.

Aspirin and medium intensity coumadin versus aspirin alone in the prevention of reocclusion after successful thrombolysis for suspected acute myocardial infarction: one-year follow-up of APRICOT-2
pp. 315-315(1)
Authors: Brouwer M.A.; van den Bergh P.J.P.C.; Kievit P.C.; Aengevaeren W.R.; Veen G.; Luijten H.E.; Hertzberger D.P.; Uijen G.J.H.; Verheugt F.W.A.

Is there still a role for physician assessment in the emergency department in the era of novel cardiac markers?
pp. 316-316(1)
Authors: Sonel A.F.; Whittle J.; Kelley M.; Wilensky R.L.

Validation of a simple electrocardiographic criterion for early risk assessment in patients with non-ST segment elevation acute myocardial infarction
pp. 316-316(1)
Authors: Barrabes J.A.; Figueras J.; Cortadellas J.; Ibars S.; Soler-Soler J.

Value of continuous risk stratification early after admission in non-ST-segment elevation acute coronary syndromes
pp. 316-316(1)
Authors: Ferreira J.M.; Aguiar C.; Timoteo A.; Santos K.R.; Seabra-Gomes R.

Abciximab partially attenuates adverse events associated with trombocytopenia: analysis of GUSTO IV ACS
pp. 316-316(1)
Authors: Williams R.T.; Sane D.C.; Damaraju L.V.; Mascelli M.A.; Barnathan E.S.; Califf R.M.; Simoons M.

Underuse of evidence-based medicine and outcome of acute myocardialinfarction patients with renal failure
pp. 316-317(2)
Authors: Tessone A.; Barbash I.M.; Gottlieb S.; Battler A.; Hasin Y.; Boyko V.; Porat A.; Behar S.; Leer J.

Chlamydia pneumoniae infection and classic risk factors in the prediction of acute myocardial infarction
pp. 317-317(1)
Authors: Kinjo K.; Sato H.; Sato H.; Shiotani I.; Ohnishi Y.; Nakatani D.; Mizuno H.; Hishida E.; Matsu-ura Y.; Kijima Y.; Hori M.

Effect of three-month antimicrobial treatment with clarithromycin in acute non-Q wave coronary syndrome
pp. 317-317(1)
Authors: Sinisalo J.P.; Mattila K.J.; Valtonen V.; Anttonen O.; Juvonen J.; Melin J.; Vuorinen-Markkola H.; Nieminen M.S.

Deterioration of risk factors is not a major determinant of coronary events in depressive patients with acute myocardial infarction
pp. 317-317(1)
Authors: Shiotani I.; Sato H.; Sato H.; Kinjo K.; Nakatani D.; Mizuno H.; Hishida E.; Ohnishi Y.; Nagata S.; Houki N.; Hori M.

BNP identifies patients with optimal reperfusion after PTCA for acute myocardial infarction
pp. 317-317(1)
Authors: Jourdain P.; Funck F.; Bellorini M.; Guillard N.; Loiret J.; Thebault B.; Desnos M.; Duboc D.

Patients on lipid-lowering therapy at the time of a myocardial infarction have smaller infarcts: further evidence to suggest a salutary effect in acute coronary syndromes
pp. 318-318(1)
Authors: Aronow H.D.; McRae T.; Quinn M.J.; Topol E.J.; Lincoff M.; Houghtaling P.L.; Lauer M.S.

Nonselective nonaspirin nonsteroidal antiinflammatory medications are associated with reduced risk of myocardial infarction
pp. 318-318(1)
Authors: Kimmel S.E.; Berlin J.A.; Reilly M.; Jaskowiak J.; Kishel L.; Strom B.L.

High fasting insulin levels in patients with coronary artery disease and no known diabetes is a potent predictor of future cardiac events
pp. 318-318(1)
Authors: Angioi M.; Theroux P.

Acute myocardial infarction and renal failure: impact of treatment on short and long-term survival
pp. 318-318(1)
Authors: Wright R.S.; Murphy J.G.; Herzog C.A.; Reeder G.S.; Miller W.L.; Kopecky S.L.; Albright R.C.; Williams B.A.; Jaffe A.S.

Bradycardia, hypotension, and chronotropic incompetence are common with acute proximal versus distal RCA occlusion
pp. 318-318(1)
Authors: Goldstein J.A.; Lee D.T.; Bowers T.; Grines C.L.; Pica M.; O'Neill W.W.

Prognostic impact of no ST segment elevation resolution in acute myocardial infarction complicated by cardiogenic shock
pp. 319-319(1)
Authors: Boutot F.; Caussanel J.M.; Gandon F.; Hazan S.; Boyer J.M.; Lambert Y.

Passive ventricular restraint with nitinol mesh attenuates remodeling following acute myocardial infarction
pp. 319-319(1)
Authors: Teekell-Taylor L.A.; Mankad S.; Dasika U.; McGregor W.E.; Biederman R.W.W.; Yamrozik J.; Trumble D.R.; Magovern J.A.

Low mortality in ischemic cardiomyopathy treated with coronary artery bypass grafting despite negative viability study
pp. 319-319(1)
Authors: Khot U.N.; Alkotob M.L.; Latif A.A.; Brunken R.C.; McCarthy P.M.; Smedira N.G.; Starling R.C.

Noninvasive assessment of internal thoracic artery graft patency by evaluating left anterior descending flow with a new transthoracic ultrasound technology
pp. 319-319(1)
Authors: Yoshitatsu M.; Miyamoto Y.; Toda K.; Fukui S.; Onishi K.

The effect of nonfatal perioperative cardiac events on long-term mortality or cardiac readmission
pp. 319-319(1)
Authors: Singh S.K.; Sykora K.; Tu J.V.; Naylor C.D.; Feindel C.M.; Lichtenstein S.V.; Fremes S.E.

Minimally invasive surgical treatment of atrial fibrillation using bipolar radiofrequency on the beating heart
pp. 319-320(2)
Authors: Prasad S.M.; Maniar H.S.; Diodato M.; Schuessler R.; Damiano R.J.

Does off pump coronary artery bypass graft surgery reduce post-operative right ventricular dysfunction?
pp. 320-320(1)
Authors: Wasan B.S.; Patel N.; Stanbridge R.; Glenville B.; Thom S.; Foale R.A.; Mayet J.

Late follow-up of the warm heart trial: eight-year results
pp. 320-320(1)
Authors: Singh S.K.; Sykora K.; Tu J.V.; Naylor C.D.; Feindel C.M.; Lichtenstein S.V.; Fremes S.E.

Effect of the angiotensin II type 1 receptor blocker candesartan on cardiovascular events
pp. 320-320(1)
Authors: Kondo J.; Sone T.; Tsubo H.; Mukawa H.; Morishima I.; Uesugi M.; Kosaka T.; Yoshida T.

Detecting myocardial ischemia from four bipolar leads reconstructed from the unipoles that are potentially available in implanted devices
pp. 320-320(1)
Authors: Ghuran A.; Wichterle D.; Little I.; Baig K.; Batchvarov V.; Camm A.J.; Pumphrey C.; Ward D.; Malik M.

Prognostic implications of ischemic mitral regurgitation in patients with myocardial infarction
pp. 321-321(1)
Authors: Pai R.G.; Varadarajan P.

Baseline risk predicts therapeutic efficacy differences between coronary bypass and coronary angioplasty
pp. 321-321(1)
Authors: Rihal C.S.; Lombardero M.S.; Silverman G.; Detre K.M.; Schaff H.V.; Gersh B.J.

Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by both sildenafil citrate and placebo
pp. 321-321(1)
Authors: Roseno G.M.; Mercuro G.; Leonardo F.; Pagnotta P.; Patrizi R.; Fini M.

Gender differences in extent and severity of coronary disease in the ACC national cardiovascular disease registry
pp. 321-321(1)
Authors: Shaw e.J.; Gibbons R.J.; McCallister B.; Mitchell K.R.; Hewitt K.; Klein L.W.; Weintraub W.S.; Brindis R.G.; Shaw R.E.

Persistent activation of the NF-K B signaling pathway in patients with unstable angina and elevated levels of C-reactive protein
pp. 321-322(2)
Authors: Liuzzo G.; Santamaria M.; Ginnetti F.; Porto A.; Angiolillo D.J.; Rizzello V.; Biasucci L.M.

Widespread coronary inflammation in patients with unstable angina
pp. 322-322(1)
Authors: Buffon A.; Biasucci L.M.; Liuzzo G.; Comerci G.; D'Onofrio G.; Crea F.; Maseri A.

Apoptosis resistance of neutrophils in patients with unstable angina
pp. 322-322(1)
Authors: Biasucci L.M.; Porto A.; Colussi C.; Lomaglio D.; Raimondi F.; Morlacchi L.; Ginnetti F.; Liuzzo G.; Maseri A.

C-reactive protein-mediated complement activation during acute myocardial infarction in humans
pp. 322-322(1)
Authors: Lagrand W.K.; Nijmeijer R.; Niessen H.W.; Visser C.A.; Hermens W.T.; Lubbers Y.P.; van Eenige M.J.; Karreman A.J.; Hack C.E.

sPLA2 potentiates binding of CRP to ischemically challenged cardiomyocytes
pp. 322-322(1)
Authors: Nijmeijer R.; Niessen H.W.; Visser C.A.; Lubbers Y.P.; Schalkwijk C.G.; Hack E.C.

C-reactive protein elevation following chemically induced septal infarction in humans without coronary atherosclerosis
pp. 322-323(2)
Authors: Lewis D.H.; Gum P.A.; Van Lente F.; Tuzcu E.M.; Lever H.

Correlation of heat production of culprit atherosclerotic lesion with soluble cell adhesion molecules
pp. 323-323(1)
Authors: Toutouzas K.; Stefanadis C.; Tsiamis E.; Vavouranakis M.; Kallikazaros I.; Vaina S.; Chrysochoou C.; Panagiotakos D.; Toutouza M.; Toutouzas P.

Endogenous endothelin-1 reduces the postischemic functional recovery of prolonged hypoperfused myocardium via the endothelin-a receptor
pp. 323-323(1)
Authors: Beyer M.E.; Fischer M.; Hoffmeister H.M.

Vasomotor function of pig coronary arteries after placement of ameroid constrictors
pp. 323-323(1)
Authors: Li J.-S.; Ueno T.; de Leon H.; Cui J.; Coussement P.K.; Chronos N.; Robinson K.A.

Heterogeneous perfusion insufficiency and three-dimensional microstructure abnormality of coronary capillary network after myocardial reperfusion
pp. 323-323(1)
Authors: Watanabe N.; Toyota E.; Shigeto F.; Kajita T.; Fujimoto K.; Ogasawara Y.; Kalya F.; Akasaka T.; Yoshida K.

Ischemic preconditioning protects the heart from membrane current changes due to ischemia
pp. 323-324(2)
Authors: Gaudette G.R.; Gao J.; Cohen I.S.; Mathias R.T.; Zuckerman J.; Irie H.; Saltman A.E.; Krukenkamp I.B.

Amlodipine increases coronary blood flow and reduces the severity of myocardial ischemia in canine hearts: roles of NO and adenosine
pp. 324-324(1)
Authors: Asanuma H.; Kitakaze M.; Node K.; Sanada S.; Ogita H.; Takashima S.; Asakura M.; Minamino T.; Tada M.; Hori M.

Distinct mechanisms of mitochondrial ATP- sensitive K channel opening by nicorandil and diazoxide: dependence of PKC activation
pp. 324-324(1)
Authors: Harada N.; Miura T.; Dairaku Y.; Iwamoto K.; Kametani R.; Ikeda Y.; Matsuzaki M.

Dobutamine-induced stress with flow restriction causes marked lactate production despite no change in myocardial oxygen consumption or fatty acid uptake
pp. 324-324(1)
Authors: Chandler M.P.; McElfresh T.A.; Huang H.; Stanley W.C.

Rapid expansion of anatomical no-reflow during reperfusion in the rabbit
pp. 324-324(1)
Authors: Reffelmann T.; Kloner R.A.

Myocardial apoptosis following short periods of ischemia in the isolated rat heart: a hypothetical cut off point for experimental simulated angina?
pp. 325-325(1)
Authors: Scarabelli T.M.; Stephanou A.; Chen-Scarabelli C.A.; Knight R.A.; Latchman D.S.

Elevated plasma levels of C-reactive protein may modulate myocardial damage in patients with acute myocardial infarction underwent successful percutaneous coronary intervention
pp. 325-325(1)
Authors: Nakagomi A.; Akutu K.; Aoki S.; Yamane Y.; Takagi H.; Fujita N.; Takano H.; Kusama Y.; Takayama M.; Takano T.

Increased collagen degradation predicts early ventricular remodelling following acute myocardial infarction
pp. 325-325(1)
Authors: McGavigan A.D.; Moncrieff J.; Maxwell P.R.; Lindsay M.M.; Dunn F.G.

Diagnosis of coronary vasospasm by detection of postischemic regional delayed relaxation or diastolic asynchrony using echocardiographic evaluation with color kinesis
pp. 325-325(1)
Authors: Ishii K.; Miwa K.; Nobuaki O.; Makita T.; Saito T.

Performance of cardiac troponin I in the exclusion of myocardial infarction in patients with advanced renal disease
pp. 326-326(1)
Authors: McCullough P.A.; Nowak R.M.; Foreback C.; Borzak S.; Tokarski G.; Tomlanovich M.C.; Jacobsen G.; Weaver W.D.; Sandberg K.R.; McCord J.

Heterogeneity of infarct sizing in non-ST segment elevation acute coronary syndromes: results from the EARLY pilot trial
pp. 326-326(1)
Authors: Roe M.T.; Christenson R.C.; Yang H.; Bahr R.; Fesmire F.M.; Mollod M.; Ohman E.M.; Gibler W.B.

Is left ventricular diastolic function an independent determinant of prognosis in patients with an acute myocardial infarction treated with thrombolysis?
pp. 326-326(1)
Authors: Quintana M.; Edner M.; Kahan T.; Sollevi A.; Rehnqvist N.; Hjemdahl P.

Is there a gender difference in the risk of arrhythmic death after acute myocardial infarction? An insight from contemporary survival studies
pp. 326-326(1)
Authors: Yee Guan Yap; Duong T.; Bland M.; Malik M.; Torp-Pederson C.; Kober L.; Connolly S.; Marchant B.; Camm A.J.

A meta-analysis of risks versus benefit of oral anticoagulation on top of aspirin following unstable angina or myocardial infarction
pp. 327-327(1)
Authors: Verheugt F.W.; Brouwer M.A.; van Es R.F.; Ezekowitz M.D.; Fiore L.; Fuster V.

Predicting survival from the coronary arteriogram: an experience-based statistical index of coronary artery disease severity
pp. 327-327(1)
Authors: Kong D.F.; Shaw L.K.; Harrell F.E.; Muhlbaler L.H.; Lee K.L.; Califf R.M.; Jones R.H.

Plasma levels of oxidized low density lipoprotein (Ox-LDL) relate to coronary events after angioplasty in patients with unstable angina pectoris
pp. 327-327(1)
Authors: Yamashita H.; Ehara S.; Naruko T.; Haze K.; Yoshiyama M.; Matsuo T.; Takeuchi K.; Yoshikawa J.; Ueda M.

Mycoplasma pneumoniae high IgA titer but not IgG predicts increased hazard of death or myocardial infarction among patients with angiographically defined coronary artery disease
pp. 327-327(1)
Authors: Lim T.H.; Muhlestein J.B.; Carlquist J.F.; Ohana B.; Lipson M.; Home B.D.; Anderson J.L.

Sudden death and diabetes mellitus: the role of parental antecedents in the Paris prospective study I
pp. 327-327(1)
Authors: Jouven X.X.; Balkau B.; Andujar L.; Desnos M.; Guerot C.; Ducimetiere P.

The Scal atrial natriuretic peptide gene wariants are associated with the extent of coronary artery disease
pp. 328-328(1)
Authors: Ciecwierz D.; Gruchala M.; Wasag B.; Targonski R.; Ochman K.; Dubaniewicz W.; Sobiczewski W.; Bellwon J.; Grzybowski A.; Curyllo B.; Rynkiewicz A.

Interleukin-6 concentration predicts coronary artery disease better than high-sensitivity C-reactive protein
pp. 328-328(1)
Authors: Davis B.P.; Muhlestein J.B.; Carlquist J.F.; Lappe' J.M.; Home B.D.; Anderson J.L.

Brain Natriuretic Peptide levels are associated with dobutamine induced myocardial ischemia
pp. 328-328(1)
Authors: Watanabe J.; Tsuji H.; Iwasaka T.; Martin M.; Morehead A.; Thomas J.; Lauer M.S.

Does the gender of the cardiologist have an impact on the noninvasive diagnosis of coronary artery disease in women and men?
pp. 328-328(1)
Authors: Wegmann B.B.; Suetsch G.; Rickli H.; Seifert B.; Muntwyler J.; Amann W.; Kiowski W.; Luescher T.F.; Turina J.; Jost C.H.A.

Value of noninvasive testing for the detection of coronary artery disease and assessment of cardiac risk in renal transplant candidates
pp. 328-329(2)
Authors: Lima J.J.; Vieira M.L.; Andrade J.L.; Martinez-Filho E.; Soares J.; Krieger E.M.

Long-term outcome of new onset exertional angina in the community: prospective eight-year follow-up compared with asymptomatic controls
pp. 329-329(1)
Authors: Gandhi M.M.; Lampe F.C.; Scantlebury A.M.; Wood D.A.

Diabetes is associated with a higher risk of death than is prior myocardial infarction in the setting of coronary disease: results from the Duke cardiovascular database
pp. 329-329(1)
Authors: McGuire D.K.; Rao S.V.; Joski P.J.; Barsness G.W.; Peterson E.D.; Jollis J.G.; Feinglos M.N.; Granger C.B.

Sex differences in the prognostic importance of diabetes in ischemic heart disease
pp. 329-329(1)
Authors: Graham M.M.; Ghal W.A.; Faris P.D.; Knudtson M.L.

High neopterin levels predict major adverse coronary events in patients with chronic stable angina
pp. 329-329(1)
Authors: Devadathan S.; Zouridakis E.; Cole D.; Kaski J.C.

Complete versus incomplete revascularization for acute myocardial infarction with killip class III or IV subsets
pp. 330-330(1)
Authors: Yamane M.; Inoue S.; Yokozuka H.

Beneficial effect of glycoprotein IIb/IIIa receptor blockers in patients undergoing primary PCI for cardiogenic shock
pp. 330-330(1)
Authors: Moscucci M.; Share D.; O'Donnell M.; DeFranco A.C.; Meengs W.L.; Maxwell-Eward A.; McGinnity J.G.; Patel K.; Kline-Rogers E.; Bondie D.; Clark V.L.; Smith D.E.; Eagle K.A.

Early revascularization is associated with improved survival in patients aged >=75 years with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry
pp. 330-330(1)
Authors: Dzavik V.; Sleeper L.A.; Saucedo J.; Hochman J.S.

Outcome of early revascularization in elderly patients with cardiogenic shock in acute myocardial infarction
pp. 330-330(1)
Authors: Prasad A.; Berger P.B.; Rihal C.S.; Holmes D.R.

LINCS: L-NMMA in cardiogenic shock: preliminary results from a prospective randomized study
pp. 330-331(2)
Authors: Cotter G.; Kaluski E.; Milovanov O.; Blatt A.; Salah A.; Hendler A.; Krakover R.; Vered Z.

Electrocardiographic left ventricular hypertrophy is associated with mortality and left ventricular rupture in patients with acute myocardial infarction
pp. 331-331(1)
Authors: Marks D.S.; Gudapati S.B.; Kleczka J.F.; Murphy S.A.; Cannon C.P.; Braunwald E.; Gibson C.M.

An intramyocardial implant system suitable for sustained-release delivery to ischemic myocardium
pp. 331-331(1)
Authors: Ueno T.; Robinson K.A.; Cui J.; Fitzgerald J.J.; Hoganson D.M.; Nash J.E.; Chronos N.

Increasing left ventricular sphericity is associated with decreased survival even in patients with TIMI-3 flow or inferior infarction
pp. 331-331(1)
Authors: Wong S.P.; French J.K.; Gao W.; White H.D.

Thrombolytic fibrin specificity influences activated partial thromboplastin time prolongation
pp. 331-332(2)
Authors: Tsikouris J.P.; Jackson K.C.; Cox C.D.; Meyerrose G.E.; Diaz J.A.; Seifert C.F.

Grafting of three-dimensional collagen type 1 scaffold on injured myocardium induces neovascularization and improves cardiac function
pp. 332-332(1)
Authors: Gaballa M.A.; Bahl J.; Morkin E.; Goldman S.

80-Lead body map detects acute ST elevation myocardial infarction missed by standard 12-lead electrocardiography
pp. 332-332(1)
Authors: Ornato J.P.; Menown I.B.; Riddell J.W.; Carley S.; Mackway-Jones K.; Higgins G.L.; Peberdy M.A.; Kontos M.C.; Maynard S.J.; Adgey A.A.J.

Rest myocardial perfusion imaging results in patients with troponin I elevations
pp. 332-332(1)
Authors: Kontos M.C.; Fratkin M.J.; Jesse R.L.; Ornato J.P.; Tatum J.L.

Infarct size limitation by gene transfer of baculoviral p35 into rat myocardium
pp. 332-332(1)
Authors: Bott-Fluegel L.; Laugwitz K.-L.; Seyfarth M.; Faltermeier C.; Baumgartner C.; Moretti A.; Schoemig A.

Comparative analyses of the prognostic value of novel cardiac markers in patients with non-ST elevation acute coronary syndromes
pp. 332-332(1)
Authors: Bazzino O.; Estrada J.N.; Botto F.; Liprandi M.I.S.; Fuselli J.J.; Santopinto J.; Ahuad R.; Nordaby R.; Salszberg S.; Prado A.H.; Lopez J.; Russo M.; Sokn F.; Perez M.; Bruno C.

C-reactive protein and other markers of inflammation in diabetic patients with unstable angina/non-ST elevation myocardial infarction
pp. 333-333(1)
Authors: Sanchez P.L.; Morinigo J.L.; Martin F.; Pabon P.; Arribas A.; Santos I.; Martin-Luengo C.

Elevated C-reactive protein in diabetics with acute coronary syndrome: culprit or innocent bystander?
pp. 333-333(1)
Authors: Chandra H.R.; Grines C.L.; O'Neill C.S.; Choudhary N.; Boura J.; Harjai K.J.; Sadeghi H.M.; Goldstein J.A.; O'Neill W.W.

C-reactive protein, pretreatment with statins, and multifocal activation of coronary artery disease in patients with primary unstable angina
pp. 333-333(1)
Authors: Zairis M.N.; Manousakis S.; Papadakie O.; Vitalis D.; Thoma M.; Tsanis E.; Matsikas T.; Papadopoulos G.; Katsaros K.; Beldekos D.; Olympios C.; Foussas S.

Can C-reactive protein predict high risk coronary angiographic findings in patients with non-ST elevation acute coronary syndromes? A large prospective cohort study
pp. 333-333(1)
Authors: Guzman-Cuneo L.A.; Estrada J.L.N.; Gabay J.; Alvarez J.; Sztejfman C.; Matas C.R.; Farras A.; Sarmiento R.; Mrad J.; Bazzino O.; De Miguel R.A.

Thrombogenic risk factors in patients who suffered a myocardial infarction under the age of 36 years
pp. 333-334(2)
Authors: Rallidis L.S.; Belesi C.I.; Manioudaki H.S.; Fakitsa V.C.; Chatziioakimidis V.K.; Laoutaris N.P.; Apostolou T.; Papasteriadis E.G.

Is age related to platelet activity in patients presenting with acute coronary syndromes?
pp. 334-334(1)
Authors: Gurbel P.A.; Ohman E.M.; Roe M.T.; Bahr R.D.; Gibler W.B.; Serebruany V.L.

Sustained reduction in coagulation activity during long-term dalteparin treatment in unstable coronary artery disease
pp. 334-334(1)
Authors: Oldgren J.; Diderholm E.; Lindmark E.; Wallentin L.; Siegbahn A.

Enhaced cortisol secretion does not control aspirin-insensitivess thromboxane biosynthesis in patients with acute coronary syndromes
pp. 334-334(1)
Authors: Renda G.; Sciulli M.G.; Seta F.; Tacconelli S.; Capone M.L.; Rebuzzi A.; Patrignani P.

Increased homocysteine levels predict a more complicated course following acute myocardial infarction
pp. 334-334(1)
Authors: Matetzky S.; Freimark D.; Ben-Ami S.; Novikov I.; Eldar M.; Hod H.

Predictors of emergency coronary artery bypass grafting in percutaneous coronary interventions
pp. 334-335(2)
Authors: Seshadri N.; Acharva N.; Houghtaling P.; Blackstone E.; Ellis S.G.; Whitlows P.L.

The effect of off pump coronary artery bypass procedures on short- and long-term survival
pp. 335-335(1)
Authors: Lawrie G.M.; Earle N.R.; Earle E.A.

Is the gastroepiloic artery suitable for intermediate coronary artery stenosis?
pp. 335-335(1)
Authors: Shimizu T.; Ito S.; Ikeda K.; Hirayama T.; Ishimaru S.; Yamashina A.

Predictors of in-hospital mortality among older diabetics undergoing coronary artery bypass grafting: results from the national cardiovascular network
pp. 335-335(1)
Authors: Veledar E.; Mahoney E.M.; Vaccarino V.; Zhang Z.; Williams J.K.; Abramson J.; Weintraub W.S.

Do all Q waves after coronary bypass surgery impact six-month prognosis?
pp. 335-335(1)
Authors: Chaitman B.; Sakai S.; Hasan F.; Gavard J.; Stocke K.; Theroux P.

The national registry of cardiopulmonary resuscitation: a preliminary report of 5,030 adult in-hospital cardiac arrests
pp. 335-336(2)
Authors: Kaye W.; Nadkarni V.; Mancini M.E.; Copes W.; Carey S.; Ornato J.P.; Truitt T.L.; Peberdy M.A.

Broad dissemination of automatic external defibrillators triples sudden cardiac arrest survival in a medium-size town
pp. 336-336(1)
Authors: Capucci A.; Piepoll M.F.; Aschieri D.; Arvedi M.; Bardy G.

Recurrence patterns after failed defibrillation of spontaneous ventricular fibrillation during acute ischemia
pp. 336-336(1)
Authors: Qin H.; Walcott G.P.; Killingsworth C.R.; Rollins D.L.; Smith W.M.; Ideker R.E.

Immediate termination of fibrillation is more likely with biphasic truncated exponential versus monophasic damped sine waveforms used for external defibrillation
pp. 336-336(1)
Authors: Tovar O.H.; Snyder D.E.; George A.R.; Jones J.L.

Optimal reperfusion in evolving myocardial infarction: does abciximab improve outcomes in stent treated patients?
pp. 336-337(2)
Authors: Masotti M.; Betriu A.

Effect of stent implantation and glycoprotein IIb/IIIa receptor blockade on target vessel revascularization in diabetics after primary PCI in acute myocardial infarction: the CADILLAC trial
pp. 337-337(1)
Authors: Stuckey T.D.; Grines C.L.; Brodie B.R.; Cox D.A.; Griffin J.J.; Carroll J.; Guagliumi G.; Garcia E.; Rutherford B.; Turco M.; Tcheng J.E.; Stone G.W.

Angiographic determinants of infarct size after successful percutaneous intervention for acute ST-T elevation myocardial infarction: the impact of distal embolization
pp. 337-337(1)
Authors: Henriques J.P.; Zijlstra F.; Ottervanger J.P.; de Boer M.-J.; Dambrink J.-H.E.; van 't Hof A.W.; Hoorntje J.C.; Suryapranata H.

Does optimal or stent-like PTCA provide equivalent outcomes compared to primary stenting in acute myocardial infarction? Early and late results from the CADILLAC trial
pp. 337-337(1)
Authors: Cox D.A.; Grines C.; Garcia E.; Stuckey T.; Tcheng J.; Guagliumi G.; Johnson A.; Lansky A.; Griffin J.; Stone G.W.

The salutary effect of prior beta blocker therapy on clinical outcomes following primary angioplasty for acute myocardial infarction: a pooled analysis from the Primary Angioplasty in Myocardial Infarction (PAMI:1), PAMI:2, and stent:PAMI trials
pp. 337-337(1)
Authors: Harjai K.J.; Stone G.W.; Boura J.; Grines L.; Garcia E.; Brodie B.; Cox D.; O'Neill W.W.; Grines C.

Acute Myocardial Infarction Study of Adenosine (AMISTAD II)
pp. 338-338(1)
Authors: Ross A.; Gibbons R.; Kloner R.A.; Marder V.J.; Stone G.W.; Alexander R.W.

Patients with coronary artery disease treated with statins have decreased heat production from culprit lesions
pp. 338-338(1)
Authors: Stefanadis C.; Toutouzas K.; Tsiamis E.; Vavouranakis M.; Kallikazaros I.; Vaina S.; Chrysochoou C.; Panagiotakos D.; Pitsavos C.; Toutouzas P.

Excessive tumour necrosis factor activation post-infarction contributes to the early susceptibility to myocardial rupture: evidence From TNF-/- transgenic knockout models
pp. 338-338(1)
Authors: Sun M.; Dawood F.; Wen W.-H.; Penninger J.; Liu P.

Sphingosine contributes to tumor necrosis factor-a-mediated contractile dysfunction in response to coronary microembolization
pp. 338-338(1)
Authors: Thielmann M.; Martin C.; Dorge H.; Belosjorow S.; Schwanke U.; Kruger A.; van de Sand A.; Konietzka I.; Schulz R.; Heusch G.

Antibodies to human heat shock protein 60 predict risk of myocardial infarction or death in women
pp. 338-339(2)
Authors: Zhu J.; Muhlestein J.B.; Nieto J.F.; Wasserman A.; Horne B.D.; Anderson J.L.; Epstein S.E.

Prognostic value of markers of myocardial damage and inflammation in low to intermediate risk chest pain patients
pp. 339-339(1)
Authors: Bholasingh R.; Cornel J.H.; Kamp O.; Windhausen A.; van der Zee M.; van Straalen J.; Sanders G.T.; de Winter R.J.

The prognostic significance of myoglobin in the emergency department in patients with chest pain
pp. 339-339(1)
Authors: McCord J.; Hudson M.P.; Nowak R.M.; Tomlanovich M.C.; Tokarski G.; Jacobsen G.; Weaver W.D.

Impact of thoracic aortic spontaneous echocardiographic contrast on long-term cardiovascular prognosis: relation to cardiac rhythm
pp. 340-340(1)
Authors: Aggeli C.; Frogoudaki A.; Lambrou S.; Brill S.; Barbetseas J.; Skoumas J.; Pitsavos C.; Stefanadis C.; Toutouzas P.

Clinical course of left atrial thrombi: a prospective and serial study with transesophageal echocardiography and cerebral magnetic resonance imaging
pp. 340-340(1)
Authors: Schmidt H.; Sommer T.; Bernhardt P.; Schild H.; Luderitz B.; Omran H.

Clinical impact of vegetation size and type of organism in patients with infective endocarditis: a transesophageal echocardiographic study
pp. 340-340(1)
Authors: Mohty D.; Coviaux F.; Pachirat O.; Sinak L.J.; Tribouilloy C.; Steckelberg J.M.; Sarano M.E.

Infective endocarditis after mitral valve repair: echocardiographic characteristics and predictors of outcome
pp. 340-340(1)
Authors: Hayek E.R.; Gillinov M.A.; Cosgrove D.M.; Griffin B.P.

Prevalence of cardiac source of embolism by transesophageal echocardiography in a young population with cerebrovascular events
pp. 340-340(1)
Authors: Vlassak I.; Thamilarasan M.; Prior D.L.; Asher C.R.; Jaber W.A.

Thromboembolic risk stratification based on SPAF clinical criteria in patients with paroxysmal atrial fibrillation and flutter: a prospective transesophageal echocardiography study
pp. 341-341(1)
Authors: Benyounes N.; Djaouti L.; Smadja C.; Albo C.; Boccara F.; Cohen A.

Specific fibrin enhancement with targeted echogenic immunoliposomes
pp. 341-341(1)
Authors: Hamilton A.J.; Huang S.; Rabbat M.; Madhav T.; Warnick D.; Nagarai A.; Klegerman M.E.; MacDonald R.C.; McPherson D.D.

Effects of various microbubble composition on the interactions with activated leukocytes
pp. 341-341(1)
Authors: Takeuchi H.; Ohmori K.; Kondo I.; Oshita A.; Shinomiya K.; Yukiiri K.; Takagi Y.; Yu Y.; Mizushige K.; Kohno M.

How well can real-time perfusion imaging by myocardial contrast echocardiography detect peri-infarction ischemia? Comparison of adenosine stress and dobutamine stress
pp. 341-341(1)
Authors: Chin C.-H.; Xing Y.-Q.; Prado A.; Gheewala R.; Nesser J.; Pandian N.G.

Myocardial opacification at intravenous myocardial contrast echocardiography depends on the depth of focus point: in vivo and in vitro study
pp. 341-342(2)
Authors: Yagura S.; Kiyoshima K.; Okazaki J.; Hirayama H.; Ohtani K.; Kashiwagi Y.; Toshida T.; Iwata A.; Kayano H.; Asanuma T.; Ishikura F.; Beppu S.

Microvascular behavior of microbubbles is strongly influenced by shell charge and polyethyleneglycol coat
pp. 342-342(1)
Authors: Fisher N.G.; Christiansen J.P.; Klibanov A.L.; Leong-Poi H.; Kaul S.; Lindner J.R.

Skin perfusion assessed by contrast ultrasound predicts tissue survival in a free flap model
pp. 342-342(1)
Authors: Christiansen J.P.; Leong-Poi H.; Amiss L.R.; Drake D.B.; Kaul S.; Lindner J.R.

Prognostic value of stress myocardial perfusion SPECT in patients with markedly reduced left ventricular function
pp. 342-342(1)
Authors: Sharir T.; Berman D.S.; Bax J.; Friedman J.D.; Hayes S.; Germano G.

Comparison of post-stress 99mTc-Sestamibi lung uptake and transient ventricular dilation in severe ischemia
pp. 342-342(1)
Authors: Marcassa C.; Galli M.; Campini R.; Calza P.; Giannuzzi P.

Do nonreversible defects affect risk of cardiac death in chronic coronary artery disease?
pp. 343-343(1)
Authors: Aboul-Enein F.A.; Berman D.S.; Hayes S.W.; Schisterman E.; Friedman J.; Germano G.

Prognostic impact of adenosine-induced hypotension in patients undergoing vasodilator stress myocardial perfusion SPECT
pp. 343-343(1)
Authors: Abidov A.; Chee Keong Ng; Hayes S.W.; Schisterman E.F.; Cohen I.; Friedman J.D.; Germano G.; Berman D.S.

Long-term survival after a normal exercise stress sestamibi study
pp. 343-343(1)
Authors: Elhendy A.; Schinkle A.; Poldermans D.; Bax J.J.; Vandomburg R.T.; Sozzi F.B.; Roelandt J.R.

Value of attenuation correction in interpretation of stress only exercise Tc-99m sestamibi SPECT imaging: results of a multicenter trial
pp. 343-343(1)
Authors: Heller G.V.; Bateman T.M.; Botvinick E.H.; Fish M.; Follansbee W.P.; Iskandrian A.; Gait J.; Haddock C.; Poston C.; Case J.A.

Is myocardial perfusion spect useful for predicting outcomes between Q wave and non-Q wave myocardial infarction?
pp. 343-344(2)
Authors: Kang X.; Berman D.S.; Schisterman E.F.; Sharir T.; Cohen I.; Hayes S.W.; Friedman J.D.; Germano G.

Management and outcome of acute chest pain: influence of age and the use of SPECT myocardial perfusion imaging
pp. 344-344(1)
Authors: Gupta A.; Hendel R.C.; Ruthazer R.; Heller G.V.; Selker H.P.; Beshansky J.R.; Pope H.J.; Woolard R.H.; Udelson J.E.

Mitral annular motion assessed by real-time three-dimensional echocardiography is related to left ventricular function defined by magnetic resonance imaging
pp. 344-344(1)
Authors: Jian Xin Qin; Shiota T.; White R.D.; Cardon L.A.; Hang X.; Greenberg N.L.; Stewart W.J.; Thomas J.D.

Fast interactive visualization of human heart in 3-D space using Real-Time three-Dimensional Echocardiographic (RT3DE) dataset on commercially available low cost computer
pp. 344-344(1)
Authors: Saracino G.; Lamberti C.; Corsi C.; Qin J.; Shiota T.; Thomas J.D.

Three-dimensional reconstruction of coronary arteriole plexus imaging using real-time contrast echocardiography
pp. 344-344(1)
Authors: Toshida T.; Kutsuyama T.; Okazaki J.; Hirayama H.; Ohtani K.; Kashiwagi Y.; Yagura S.; Iwata A.; Asanuma T.; Ishikura F.; Beppu S.

Accuracy of three-dimensional echocardiographic measurements of mitral valve orifice area using transthoracic free-hand scanning
pp. 345-345(1)
Authors: Sugeng L.; Lammertin G.; Weinert L.; Korcarz C.E.; Bednarz J.E.; Spencer K.T.; Feldman T.; Lang R.M.

Quantification of variable geometry laminar flow volumes using three-dimensional digital color doppler: an in vitro study
pp. 345-345(1)
Authors: de la Cruz J.S.; Li X.; DeChant C.E.; Davies C.H.; Xiang-Ning Li; Sahn D.J.

Calculation of cardiac output by measurement from tricuspid inflow using a 3-D digital color doppler method: an in vivo validation study
pp. 345-345(1)
Authors: Mack G.K.; Wanitkun S.; Mehwald P.S.; Zetts A.D.; Detmer P.R.; Lennon D.; Sahn D.J.

Validation of real-time three-dimensional echocardiography for quantifying right ventricular volume: an in vitro study in static and pulsatile RV models
pp. 345-345(1)
Authors: Schindera S.T.; Mahwald P.S.; Rusk R.A.; Goebel H.; Kececioglu D.; Sahn D.J.

The optimum hypoglycemic therapy can improve coronary flow velocity reserve in diabetic patients: demonstration by transthoracic doppler echocardiography
pp. 346-346(1)
Authors: Miyazaki C.; Takeuchi M.; Yoshitani H.; Otani S.; Sakamoto K.; Yoshikawa J.

Assessment of the reduction of coronary flow velocity reserve in patients with diabetic retinopathy by transthoracic doppler echocardiography
pp. 346-346(1)
Authors: Miyazaki C.; Takeuchi M.; Yoshitani H.; Otani S.; Sakamoto K.; Yoshikawa J.

Transthoracic echocardlographic measurement of coronary flow reserve in the right coronary artery: comparison with invasive data
pp. 346-346(1)
Authors: Lethen H.; Tries H.P.; Kersting S.; Lambertz H.

Noninvasive measurements of coronary collateral flow velocity using transthoracic doppler echocardiography
pp. 346-346(1)
Authors: Watanabe N.; Yamaura Y.; Akiyama M.; Neishi Y.; Koyama Y.; Kaji S.; Saito Y.; Kamiyama N.; Suetsuna R.; Akasaka T.; Yoshida K.

Noninvasive assessment of coronary flow velocity pattern by transthoracic color doppler echocardiography can predict adverse cardiac events in reperfused anterior wall acute myocardial infarction
pp. 346-346(1)
Authors: Katayama M.; Yamamuro A.; Ueda Y.; Tamita K.; Yamabe K.; Ibuki M.; Mizoguchi S.; Takagi T.; Tanabe K.; Nagai K.; Tani T.; Yagi T.; Morioka S.

Serial measurement of coronary flow velocity by transthoracic doppler echocardiography: prediction of left ventricular remodeling in reperfused acute myocardial infarction
pp. 347-347(1)
Authors: Lee S.; Minagoe S.; Otsuji Y.; Toda H.; Toyonaga K.; Tsurugida M.; Okamura M.; Yamashita T.; Hamasaki S.; Tei C.

In vivo quantification of viability: magnetic resonance detects small scar regions in metabolically viable segments
pp. 347-347(1)
Authors: Schwitter J.; Nanz D.; Knuesel P.R.; Wyss C.; Buechi M.; Kaufmann P.A.; Luescher T.F.; von Schulthess G.K.

Assessment of myocardial viability using contrast-enhancedmagnetic resonance imaging: comparison with FDG-PET and sestamibi-SPECT
pp. 347-347(1)
Authors: Kuhl H.P.; van der Weerdt A.P.; Beek A.M.; Visser C.A.; Visser F.C.; van Rossum A.C.

Comprehensive assessment of coronary artery disease with magnetic resonance imaging
pp. 347-347(1)
Authors: Plain S.; Ridgway J.P.; Jones T.R.; Bloomer T.N.; Sivananthan M.U.

Determination of myocardial viability after myocardial infarction using contrast-enhanced magnetic resonance imaging: comparison to thallium SPECT
pp. 347-348(2)
Authors: Regenfus M.; Schlundt C.; Schmiedehausen K.; Ropers D.; Achenbach S.; Schmidt M.; Oesingmann N.; Platsch G.; Kuwert T.; Moshage W.; Daniel W.G.

Value of stress myocardial perfusion and delayed enhanced magnetic resonance imaging for noninvasive screening of coronary artery disease before elective repair of aortic aneurysm
pp. 348-348(1)
Authors: Ishida M.; Sakuma H.; Kato N.; Ishida N.; Shimono T.; Yada I.; Takeda K.

The importance of absolute quantitation for multislice MRI myocardial perfusion during vasodilator stress
pp. 348-348(1)
Authors: Christian T.F.; Liao S.; Aletras A.H.; Balaban R.S.; Arai A.E.

Whole-heart dipyridamole stress first-pass myocardial perfusion MRI for the detection of coronary artery disease with and without prior myocardial infarction
pp. 348-348(1)
Authors: Takase B.; Nagata M.; Kihara T.; Hosaka H.; Hara A.; Kamezawa A.; Noya K.; Kurita A.; Anzai H.; Sakurada M.; Ohsuzu F.

Three-dimensional visualization of electrophysiologic landmarks : a intracardiac echocardiography (ICE) study
pp. 348-348(1)
Authors: Vogtmann T.; Volkmer M.; Ernst S.; Ouyang F.; Goya M.; Antz M.; Kuck K.-H.

Use of three-dimensional intracardiac echocardiography for assessment of pulmonary vein anatomy and lasso catheter localization
pp. 349-349(1)
Author: Simon R.D.

Geometry of tricuspid annulus determined by real-time 3-D echo in tricuspid regurgitant patients with intact leaflets
pp. 349-349(1)
Authors: Jian Xin Qin; Shiota T.; Yong Jin Kim; Agler D.A.; Hang X.; Kwan J.; McCarthy P.M.; Thomas J.D.

Transesophageal echocardiographic guidance of catheter closure of ventricular septal defects in children and adults
pp. 349-349(1)
Authors: Du Z.-D.; Cao Q.-L.; Koenig P.; Waight D.; Heitschmidt M.; Hijazi Z.M.

Implantation of permanent pacemakers guided by transthoracic echocardiography
pp. 349-349(1)
Authors: Fuentes G.D.D.; Petrozi M.; Pacheco P.; Diaz A.

Descending aortic doppler velocities after balloon-expandable stent implantation for coarctation of the aorta: are they related to pressure changes by the Bernoulli Equation?
pp. 349-350(2)
Authors: Schindera S.T.; Young M.T.; Li X.; Giraud G.D.; Wang H.; Burch G.H.; Kececioglu D.; Sahn D.J.

Outcome of patients after exercise echocardiogram suggestive of single vessel coronary artery disease
pp. 350-350(1)
Authors: Elhendy A.; Khandheria B.K.; Mahoney D.; Paterick T.E.; Burger K.; Pellikka P.A.

Which is accurate to detect the coronary stenosis using adenosine triphosphate stress test? Wall motion abnormality or replenishment curve analysis of real-time myocardial contrast echocardiography
pp. 350-350(1)
Authors: Ishikura F.; Ohtani K.; Okazaki J.; Hirayama H.; Kashiwagi Y.; Yagura S.; Toshida T.; Iwata A.; Kayano H.; Asanuma T.; Beppu S.

Effective predischarge triage at the emergency room with dobutamine stress echocardiography and cardiac troponin T
pp. 350-350(1)
Authors: Bholasingh R.; Cornel J.H.; Kamp O.; van Straalen J.P.; Sanders G.T.; Tijssen J.G.; Umans V.A.; Visser C.A.; de Winter R.J.

Does real-time perfusion have any incremental value for the sensitivity and specificity of dobutamine stress echocardiography?
pp. 350-350(1)
Authors: Dolan M.S.; El-Shafei A.; Bierig M.; Doshi A.; Sklenar J.; Singh T.; Sheriff D.; Maniet A.; Kem M.; Labovitz A.J.

Noninvasive evaluation of left anterior descending coronary flow after slidenafil citrate (Viagra) administration by doppler echocardiography in normal subjects
pp. 351-351(1)
Authors: Ishikura F.; Beppu S.; Khandheria B.K.; Nehra A.

Echocardiographic ischemia is a predictor of death in patients after bypass surgery in the setting of left ventricular dysfunction
pp. 351-351(1)
Authors: Thamilarasan M.; Rodriguez L.; Thomas J.D.; Lauer M.S.

Dobutamine stress echocardiography unmasks global left ventricular dysfunction in children with ''normal'' coronary arteries following kawasaki disease
pp. 351-351(1)
Authors: Witt S.; Glascock B.; Michelfelder E.; Kimball T.

Prognostic value of normal stress echocardiography in the presence of a markedly positive stress electrocardiogram
pp. 351-351(1)
Authors: Mahenthiran J.; Singh B.K.; Yao S.-S.; Chaudhry F.A.

Detection of stenotic coronary artery bypass grafts and recipient vessels with magnetic resonance imaging
pp. 351-352(2)
Authors: Langerak S.E.; Vliegen H.W.; Jukema W.; Kunz P.; Zwinderman A.H.; Lamb H.J.; de Roos A.; van der Wall E.E.

Noninvasive detection of internal carotid artery stenosis: a head-to-head comparison between ultrasonography and magnetic resonance angiography
pp. 352-352(1)
Authors: Cosottini M.; Pingitore A.; Michelassi M.C.; Puglioli M.; Calabrese R.; Lombardi M.

Real-time MRI angioplasty using intravascular guidewire coils
pp. 352-352(1)
Authors: Dick A.J.; Guttman M.A.; Raman V.K.; Peters D.C.; Thompson R.B.; Lederman R.J.

Magnetic resonance imaging guided deployment and postinterventional assessment of endovascular stents in the pulmonary position in swine
pp. 352-352(1)
Authors: Kuehne T.; Moore P.; Saeed M.; Gleason K.; Weber O.; Turner D.; Teitel D.; Higgins C.B.

Intravascular guidewire coil facilitated invasive real-time magnetic resonance arteriography
pp. 352-352(1)
Authors: Raman V.K.; Guttman M.A.; Dick A.J.; Peters D.C.; Thompson R.B.; Lederman R.J.

Effect of time and energy on magnetic resonance imaging of acute radiofrequency ablation lesion
pp. 353-353(1)
Authors: Dickfeld T.; Kato R.; Meininger G.; Licklett L.; Berger R.; Calkins H.; Halperin H.

Absence of inotropic contractile reserve is a strong predictor of cardiovascular mortality in patients with nonischemic cardiomyopathy
pp. 353-353(1)
Authors: Zakir R.M.; Kowalski M.; Yao S.-S.; Chaudhry F.A.

Usefulness of tissue velocity imaging technique in the detection of multi vessel coronary artery disease during dobutamine stress echocardiography
pp. 353-353(1)
Authors: Wada Y.; Murata K.; Tanaka N.; Ueda K.; Liu J.; Ohyama R.; Harada N.; Hamada Y.; Matsuzaki M.

Effects of acute myocardial ischemia on QT dispersion: evaluation by dipyridamole-stress echocardiography
pp. 353-353(1)
Authors: Carluccio E.; Biagioli P.; Bentivoglio M.; Mariotti M.; Politano M.; Savino K.; Sardone M.; Locati E.H.; Ambrosio G.

Functional effect of glucose, insulin, and potassium in patients with chronic ischemic left ventricular dysfunction
pp. 353-353(1)
Authors: Khoury V.; Haluska B.; Marwick T.H.

Effect of a 48-hour discontinuation of beta blockers before dobutamine atropine stress echocardiography on the occurrence of sustained arrhythmic events during the test
pp. 354-354(1)
Authors: Bouziane B.; Brahim H.; Waheedur R.; Inthidar N.; Valerie P.; Hassan S.; Bernard Z.; Antoine B.; Ariel C.

Noninvasive diagnosis of physiologic stenosis in the left circumflex coronary artery using contrast enhanced transthoracic Doppler echocardiography: comparison with exercise 201-TI Single Photon Emission Computed Tomography
pp. 354-354(1)
Authors: Tokai K.; Watanabe H.; Yamagishi H.; Hirata K.; Otsuka R.; Muro T.; Yoshiyama M.; Yoshikawa J.

The doppler flow characteristics of the grafted left internal mammary provide diagnostic information for patency over stress TI201 scintigraphy and dobutamine
pp. 354-354(1)
Authors: Athanassopoulos G.; Koutsogiannis N.; Motsi A.; Karatasakis G.; Cokkinos D.V.

Assessment of myocardial contractile reserve during dobutamine stress echocardiography in patients with coronary artery disease by the novel index of contractile function: myocardial acceleration during isovolumic contraction
pp. 354-354(1)
Authors: Pauliks L.B.; Madler C.F.; Williams R.I.; Vogel M.; Redington A.N.; Payne N.; Fraser A.G.

Reconstructive three-dimensional tissue doppler imaging for quantifying left ventricular myocardial infarction area after coronary artery occlusion: an in vivo chronic animal study
pp. 354-355(2)
Authors: Wang H.; Li X.; Jones M.; Davies C.H.; Swanson-Birchill J.C.; Rusk R.A.; Schindera S.T.; Zetts A.D.; Lie G.R.; Sahn D.J.

Myocardial velocity gradients within segments having resting wall motion abnormalities predict contractile reserve as determined by Dobutamine echocardiography
pp. 355-355(1)
Authors: Torres M.R.; Yuda S.; Short L.; Haluska B.; Marwick T.H.

Quantitative Doppler tissue imaging using free-hand 3-D echo to assess regional myocardial velocities is feasible
pp. 355-355(1)
Authors: Nandalur M.R.; Douglas P.; Rahko P.; Breburda C.S.

Noninvasive assessment of the force frequency relationship by a novel tissue doppler-based index of contractile function: myocardial acceleration during isovolumic contraction in an animal experiment
pp. 355-355(1)
Authors: Schmidt M.R.; Kristiansen S.B.; Vogel M.; White P.A.; Sorensen K.E.; Redington A.N.

Parallel systolic and diastolic dysfunction in Hypertensive hypertrophy with normal ejection fraction: insights from doppler tissue imaging
pp. 355-355(1)
Authors: Aurigemma G.P.; Vinch C.S.; Hill J.C.; Meyer T.E.; Tighe D.A.

Evaluation of resynchronization of contractile function following biventricular pacing using colour tissue doppler imaging
pp. 356-356(1)
Authors: Bax J.J.; Marwick T.; van Erven L.; Molhoek S.; Adriaansche C.; de Melker R.; Voogd P.; van der Wall E.; Schalij M.

Quantitative three-dimensional echocardiography using an ultrafast rotating transthoracic scanner for evaluation of ventricular function in humans
pp. 356-356(1)
Authors: Kasprzak J.D.; Plewka M.; Lancee C.T.; de Jong N.; Vletter W.B.; Mastik F.; van der Steen A.F.W.; Ten Cate F.J.; Born N.

Risk factor associations with coronary calcium: a 4-slice multidetector CT study with prospective ECG triggering in 2,030 subjects
pp. 356-356(1)
Authors: Schmermund A.; Erbel R.; Silber S.

Age and gender distribution of coronary artery calcium measured by 4-slice-CT in 2030 individuals asymptomatic for coronary artery disease
pp. 356-356(1)
Authors: Silber S.; Schmermund A.; Erbel R.

Evaluation of rapamycin coated stents by multi row detector computed angiography: comparison to quantitative angiographic results
pp. 357-357(1)
Authors: Pinto I.M.; Ishikawa W.; Sousa A.; Mattos L.; Feres F.; Abizaid A.; Abizaid A.; Souza L.; Sousa J.E.

Coronary calcium score is influenced by the image reconstruction interval in retrospectively ECG-gated multi-slice spiral CT
pp. 357-357(1)
Authors: Sinha A.M.; Mahnken A.; Wildberger J.; Hoffmann R.; Guenther R.W.; Hanrath P.

Electron beam tomography permits to noninvasively rule out coronary artery stenoses in patients scheduled for noncoronary cardiac surgery
pp. 357-357(1)
Authors: Achenbach S.; Ropers D.; Hauer S.; Menendez T.; Pohle K.; Maeffert R.; Kusus M.; Regenfus M.; Moshage W.; Daniel W.G.

Feasibility of simultaneous imaging of myocardial perfusion and regional left ventricular function using color-encoded contrast-enhanced power modulation
pp. 357-357(1)
Authors: DeCara J.M.; Mor-Avi V.; Spencer K.T.; Weinert L.; Bednarz J.E.; Lang R.M.

Cyclic changes in myocardial stiffness over the cardiac cycle as measured using a new ultrasound method, vibro-acoustography: findings in normal and infarcted myocardium
pp. 358-358(1)
Authors: Pislaru C.; Anagnostopoulos P.; Kinnick R.R.; Greenleaf J.F.

Tissue displacement imaging: second-generation tissue doppler with angle correction and quantitative color-coded wall displacement for assessment of regional ventricular function
pp. 358-358(1)
Authors: Sade E.; Severyn D.A.; Gorcsan J.

Systolic intraventricular pressure gradients measured by color-doppler M-mode: a new tool to assess ventricular hemodynamics
pp. 358-358(1)
Authors: Yotti R.; Bermejo J.; Antoranz C.; Allue C.; Moreno J.L.R.M.; Garcia-Fernandez M.A.

Ambulatory echocardiography using a novel ultrasound transducer: preliminary observations
pp. 358-358(1)
Authors: Chandraratna P.A.; Vijayasekaran S.; Basheer M.; Niguse G.

Ethnicity and calcified atherosclerosis: can data on coronary calcium be applied evenly across ethnic groups? Results from the prospective army coronary calcium project
pp. 359-359(1)
Authors: Lee T.C.; O'Malley P.G.; Feuerstein I.; Taylor A.J.

Sub-clinical atherosclerosis in hypertensive individuals: the role of conditional risk factors
pp. 359-359(1)
Authors: Kullo I.J.; McConnell J.P.; Bielak L.F.; Peyser P.A.; Kardia S.L.; Sheedy P.F.; Boerwinkle E.; Turner S.T.

Plasma homocysteine and not C-reactive protein predicts progression of atherosclerosis
pp. 359-359(1)
Authors: Rasouli M.L.; Budoff M.J.; Park R.; Aziz D.

Coronary calcifications in young patients with first, unheralded myocardial infarction: a risk factor matched analysis by electron beam tomography
pp. 359-359(1)
Authors: Pohle K.; Ropers D.; Geitner P.; Menendez T.; Regenfus M.; Moshage W.; Daniel W.G.; Achenbach S.

What is the relationship between extent of calcification and true atherosclerotic burden in vivo? A volumetric intravascular ultrasound analysis
pp. 359-360(2)
Authors: Tinana A.M.; Mintz G.S.; Weissman N.J.

Development of an angiogenesis-targeted microbubble ultrasound contrast agent
pp. 360-360(1)
Authors: Leong-Poi H.; Klibanov A.L.; Christiansen J.P.; Huo Y.; Lindner J.R.

Myocardial contrast echocardiography can be used to detect acute heart transplant rejection
pp. 360-360(1)
Authors: Lu E.; Black M.M.; Fischer D.; Wagner W.R.; Villanueva F.S.

Dynamics of ischemia-reperfusion injury evaluated by real-time myocardial contrast echocardiography: protective effects of a novel endothelin A antagonist BSF 461314
pp. 360-360(1)
Authors: Hansen A.E.; Bekeredjian R.; Filusch A.; Gross M.-L.; Muenter K.; Gebhardt M.; Broillet A.; Kuecherer H.

Albumin microbubbles can be targeted to activated neutrophils in vivo: application to assessment of the neutrophils infiltration pattern produced by ischemia/reperfusion
pp. 360-361(2)
Authors: Kondo I.; Ohmori K.; Oshita A.; Takeuchi H.; Shinomiya K.; Yu Y.; Takagi Y.; Yukiiri K.; Wada Y.; Mizushige K.; Kohno M.

Transfection of plasmid DNA in cardiac and skeletal muscle with ultrasound and intravenous cationic microbubble vehicles
pp. 361-361(1)
Authors: Christiansen J.P.; Klibanov A.L.; Lindner J.R.

Prognostic significance of ischemic electrocardiographic changes during adenosine infusion in patients with normal myocardial perfusion imaging
pp. 361-361(1)
Authors: Afshar M.; Abbott B.G.; Berger A.K.; Wackers F.J.

Prognostic value of stress-induced ischemia versus rest redistribution thallium-201 SPECT
pp. 361-361(1)
Authors: Sharir T.; Berman D.S.; Bax J.; Friedman J.D.; Hayes S.; Germano G.

The Nuclear Utility in the Community (NUC) study: myocardial perfusion imaging predicts clinical outcomes in a community-based outpatient practice
pp. 361-361(1)
Authors: Thomas G.S.; Miyamoto M.I.; Hayashida C.S.; Morello A.P.; Majmundar H.; Payne M.M.; Ondatje J.T.; Thomas J.J.; Shaw L.J.; Hachamovitch R.

Prognostic value of normal Tc-99m myoview SPECT imaging: preliminary results from the myoview multicenter registry in 4,728 patients
pp. 361-362(2)
Authors: Shaw L.J.; Hendel R.; Borges-Neto S.; Burnette J.; Hachamovitch R.; Krawczynska E.; Alazraki N.; Cerqueira M.; Maddahi J.

Prognostic implication of significant ST segment depression during exercise in patients with normal myocardial perfusion SPECT imaging
pp. 362-362(1)
Authors: Chee Keong Ng; Hayes S.; Berman D.S.; Friedman J.D.; Germano G.

Quantification of myocardial blood flow velocity reserve with contrast echocardiography allows detection of milder stenoses compared to ^99mTc-sestamibi SPECT
pp. 362-362(1)
Authors: Rinkevich D.; Shivalkar B.; Dawson D.; Belcik T.; Kaul S.; Wei K.

Contrast echocardiography is superior to single photon emission computed tomography for detection of coronary stenosis
pp. 362-362(1)
Authors: Lepper W.; Franke A.; Kaul S.; Hanrath P.; Hoffmann R.

Accuracy and negative predictive value of adenosine contrast echocardiography are higher in patients with single vessel than multivessel coronary artery disease
pp. 362-363(2)
Authors: Moraes A.; Medeiros C.; Morcerf F.; Carrinho M.; Castier M.; Nogueira A.C.; Salek F.; Dohmann H.

Myocardial contrast echocardiography with triggered ultrasound does not cause ventricular premature beats: evidence from PB127 studies
pp. 363-363(1)
Authors: Raisinghani A.B.; Wei K.; Crouse L.; Villanueva F.; Feigenbaum H.; Schiller N.B.; Aggarwal P.; Weiss J.; Naqvi T.Z.; Siegel R.; Goldman J.H.; Monaghan M.; DeMaria A.

Quantitative real-time myocardial contrast echocardiography for detection of coronary artery disease: comparison with MIBI SPECT and coronary angiography
pp. 363-363(1)
Authors: Peltier M.; Pasquet A.; d'Hondt A.-M.; Vancraeynest D.; Ay T.; Melin J.; Vanoverschelde J.-L.

Infarct-related artery patency can be assessed by quantification of myocardial blood flow velocity with contrast echocardiography
pp. 363-363(1)
Authors: Balcells E.; Lepper W.; Kaul S.; Lindner J.R.; Belcik T.; Powers E.; Wei K.

Continuous hands-free monitoring of pericardiocentesis using a novel ultrasound transducer
pp. 363-363(1)
Authors: Chandraratna P.A.; Tzeng J.; Vijayasekaran S.; Agopian E.

A new method of lateral compensation of acoustic power for homogenous acoustic field: its efficacy at intravenous myocardial contrast echocardiography
pp. 364-364(1)
Authors: Toshida T.; Ohtani K.; Okazaki J.; Hirayama H.; Kashiwagi Y.; Yagura S.; Iwata A.; Asanuma T.; Ishikura F.; Kawagishi T.; Mine Y.; Beppu S.

Second harmonic modality improves capability of integrated backscatter in detecting viable myocardium during echo dobutamine test
pp. 364-364(1)
Authors: Colonna P.; Montisci R.; Cadeddu C.; Onnis E.; Chen L.; Meloni L.; Iliceto S.

Value of novel ultrasonic radio frequency signals analysis in assessing effect of aldosterone inhibition on cardiac structural abnormality
pp. 364-364(1)
Authors: Nishikawa N.; Masuyama T.; Yamamoto K.; Mano T.; Sakata Y.; Yoshida J.; Hori M.

Diagnostic digital echocardiography on devon island via telemedicine as a mars analog
pp. 364-364(1)
Authors: Smith R.L.; Jones J.; McGinnis P.; Butler D.; Effenhauser R.; Melton S.; Sargasyan A.; Martin D.; Garcia M.; Thomas J.

Color M-mode estimation of the spatial distribution of the diastolic intraventricular pressure gradient with a left ventricular aneurysm
pp. 364-364(1)
Authors: Watanabe J.; Jones M.; Shiota T.; Tsujino H.; Greenberg N.L.; Popovic Z.B.; Zetts A.D.; Jian Xin Qin; Cardon L.A.; Garcia M.J.; Thomas J.D.

Measurement of myocardial infarct size in mice using pinhole single photon emission computed tomography
pp. 365-365(1)
Authors: Wu M.C.; Sievers R.E.; Dong Wei Gao; Lee R.J.; Hasegawa B.H.; Dae M.W.

Evidence for increased angiotensin II type 1 receptor immunoreactivity in peri-infarct myocardium of human explanted hearts
pp. 365-365(1)
Authors: Dilsizian V.; Loredo M.; Ferrans V.J.; Jagoda E.M.; Eckelman W.C.; Shirani J.

Reduced metabolic reserve in both right and left ventricles in patients with heart failure
pp. 365-365(1)
Authors: Ukkonen H.; Beanlands R.; Knuuti J.; Voipio-Pulkki L.-M.

Comparison of the prognostic value of cardiac I-123 metaiodobenzylguanidine imaging and heart rate variability in patients with mild to moderate chronic heart failure
pp. 365-365(1)
Authors: Yamada T.; Fukunami M.; Shimonagata T.; Kumagai K.; Hirata A.; Asai M.; Makino N.; Kioka H.; Hoki N.

B1-adrenergic receptor gene polymorphism modulates cardiac sympathetic innervation in patients with dilated cardiomyopathy
pp. 365-366(2)
Authors: Iwai C.; Akita H.; Shiga N.; Takai E.; Miyamoto Y.; Shimizu M.; Fujiwara S.; Kawai H.; Yamada S.-i.; Takarada A.; Kajiya T.; Yokoyama M.

Functional fate after revascularization of myocardium with intact perfusion but without contractile reserve
pp. 366-366(1)
Authors: Bax J.J.; Schinkel A.; Boersma E.; Elhendy A.; Poldermans D.

Comparison of fluorodeoxyglucose positron emmission tomograpy and nonfluoroscopic electroanatomical mapping in myocardial viability assessment
pp. 366-366(1)
Authors: Gyonayosi M.; Graf S.; Glogar D.; Khorsand A.; Pirich C.; Sochor H.; Porenta G.

Left ventricular functional impairment in chronic heart failure patients is independent of extent of perfusion defects and viable myocardium
pp. 366-366(1)
Authors: Oxilia-Estigarribia M.A.; Sayre J.; Fonarow G.; Schelbert H.R.

Insulin improves myocardial microcirculation reperfusion after acute ischemia with hyperglycemia
pp. 366-366(1)
Authors: Jiang L.; Shen X.; Lof J.; Porter T.R.

Color-coded curved anatomical M-mode analysis of contrast echocardiography: a novel technique for the diagnosis of coronary artery stenosis
pp. 366-367(2)
Authors: Iwata A.; Okazaki J.; Ohtani K.; Hirayama H.; Kashiwagi Y.; Yagura S.; Toshida T.; Asanuma T.; Ishikura F.; Beppu S.

Premature ventricular contractions induced during contrast aided echocardiography are associated with microvascular leakage
pp. 367-367(1)
Authors: Li P.; Cao L.; Dou C.; Armstrong W.F.; Miller D.

Hyperglycemia worsens myocardial microcirculation reperfusion: validation by power pulse inversion imaging and neutron activated microspheres
pp. 367-367(1)
Authors: Shen X.; Porter T.R.; Lof J.; Jiang L.

Gold-bound microtubules as a new ultrasound contrast agent
pp. 367-367(1)
Authors: Kuecherer H.F.; Behrens S.; Bekeredjian R.; Ruef J.; Dinjus E.; Baum M.; Unger E.

Left ventricular thrombus enhancement following intravenous echogenic immunoliposome injection
pp. 367-367(1)
Authors: Hamilton A.J.; Rabbat M.; Huang S.; Stein A.; Madhav T.; Kane B.J.; Klegerman M.E.; MacDonald R.C.; McPherson D.D.

The safety of clinical cardiovascular magnetic resonance imaging: a single-center experience in more than 3,000 cases
pp. 368-368(1)
Authors: Friedrich M.G.; Schulz-Menger J.; Strohm O.; Lankes W.; Poetsch T.; Dietz R.

Criteria for concentric left ventricular geometry determined using magnetic resonance imaging
pp. 368-368(1)
Authors: Chuang M.L.; Salton C.J.; O'Donnell C.J.; Kissinger K.V.; Levy D.; Manning W.J.

Results of a dose-ranging diagnostic trial of magnetic resonance angiography with MS-325, a blood pool contrast agent, for the detection of vascular occlusive disease in the aortoiliac region
pp. 368-368(1)
Authors: Leon M.; Mohler E.

Is magnetic resonance imaging a reliable tool for quantifying aortic valve stenosis?
pp. 368-368(1)
Authors: Caruthers S.D.; Lin R.; Watkins M.P.; Brown P.; Lehr K.; McKinney L.; Lanza G.M.; Wickline S.A.

Rapid evaluation of right ventricular volume and mass without breath-holding using real-time interactive cardiac magnetic resonance imaging system
pp. 368-369(2)
Authors: Kaji S.; Yang P.C.; Kerr A.B.; Meyer C.H.; Pauly J.M.; Hu B.S.

Cardiac cine magnetic resonance imaging identifies anatomical and functional abnormalities in patients with arrhythmias of right ventricular origin
pp. 369-369(1)
Authors: Croitoru M.; Muthupillai R.; Seger J.J.; Massumi A.; Lopez A.; Flamm S.

Effect of spinal cord stimulation on cardiac adrenergic nervous fiber function in patients with angina and normal coronary arteries
pp. 369-369(1)
Authors: Lanza G.A.; Sestito A.; Sandric S.; Crea F.; De Seta F.; Bellocci F.; Maseri A.

Left bundle branch block and quantitative regional myocardial bloodflow patterns in humans - adenosine vs. bicycle stress in PET
pp. 369-369(1)
Authors: Koepfli P.; Wyss C.A.; Siegrist P.T.; von Schulthess G.K.; Kaufmann P.A.

Verapamil attenuates the coronary vasodilatory response to adenosine and A_2A adenosine receptor agonists
pp. 369-369(1)
Authors: Riou L.M.; Ruiz M.; Rieger J.M.; Macdonald T.L.; Watson D.D.; Linden J.; Beller G.A.; Glover D.K.

Effect of tetrahydrobiopterin on coronary microcirculation in healthy and hypercholesterolemic subjects
pp. 370-370(1)
Authors: Koeplli P.; Wyss C.A.; Siegrist P.T.; Schoedon G.; Berthold T.; Kaufmann P.A.

Detection and reproducibility of mental stress induced ischemia utilizing Tc-99m sestamibi single-photon emission tomography in normal and coronary artery disease population
pp. 370-370(1)
Authors: Kim C.K.; Bartholomew B.A.; Sheffield D.; Mastin S.; Marsh M.; Tassan V.C.; Sheps D.S.

Sestamibi perfusion imaging predicts wall motion recovery beyond TIMI grade 3 flow following primary stenting
pp. 370-370(1)
Authors: Godov S.A.; Belziti C.A.; Berrocal D.H.; Gabay J.M.; Oberti P.; Pizarro R.; Falconi M.; Jager V.; Parysow O.; Grinfeld L.R.; Cohen M.G.

Improved quantification of Tc-99m sestamibi myocardial perfusion attenuation corrected SPECT imaging
pp. 370-370(1)
Authors: Garcia E.V.; Folks R.D.; Cooke D.; Gait J.R.; Case J.A.; Cullom J.; Bateman T.M.

Evaluation of peripheral blood flow during exercise: a complement to exercise myocardial perfusion SPECT for prognostic assessment
pp. 370-370(1)
Authors: Qureshi E.A.; Rozanski A.; Chouraqui P.; Reed G.; Donnelly J.; Armenia A.

Phenylephrine stress echocardiography: a new pharmacologic test to evaluate mitral regurgitation
pp. 371-371(1)
Authors: Nash P.J.; Stewart W.J.

QTc interval shortening during dipyridamole stress test predicts severe coronary artery disease in patients with left bundle-branch block
pp. 371-371(1)
Authors: Bertella M.; Scalise F.; Valentini P.; Eriano G.; Valentini R.; Nanna M.

Comparative prognostic value of dobutamine versus dipyridamole stress echocardiography for perioperative cardiovascular risk assessment in patients undergoing major vascular surgery
pp. 371-371(1)
Authors: Kertai M.D.; Rosa S.; L'Italien G.J.; Roelandt J.R.T.C.; Poldermans D.

Vasospasm in acute coronary syndrome: does ergonovine stress echocardiogram have a role?
pp. 371-371(1)
Authors: Kim M.H.; Park T.H.; Yang D.K.; Oh W.; Cha K.S.; Kim Y.D.; Kim J.S.

Postinfarction myocardial viability diagnosis with integrated backscatter cyclic variations during dobutamine infusion
pp. 371-372(2)
Authors: Colonna P.; Montisci R.; Cadeddu C.; Meloni L.; Iliceto S.

Validation of TEI index in the estimation of cardiac function: an experimental study
pp. 372-372(1)
Authors: Yoshifuku S.; Biro S.; Ikeda Y.; Kamogawa Y.; Otsuji Y.; Minagoe S.; Tei C.

Evaluation of left ventricular contractile function using noninvasively derived end-systolic elastance in mitral regurgitation: experimental validation and clinical study
pp. 372-372(1)
Authors: Yong Jin Kim; Jones M.; Shiota T.; Jian Xin Qin; Greenberg N.L.; Popovic Z.B.; Kwan J.; Sitges M.; Bauer F.; Yang H.; Cardon L.A.; Sachdev V.; Griffin B.P.; Cosgrove D.M.; Thomas J.D.

Is noninvasive evaluation of pulmonary vascular resistance possible?
pp. 372-372(1)
Authors: Abbas A.E.; Fortuin F.D.; Schiller N.B.; Appleton C.P.; Moreno C.A.; Lester S.J.

Peak early diastolic velocity by tissue doppler imaging is a better predictor of mortality than standard doppler-echo measurements
pp. 372-373(2)
Authors: Wang M.; Yip G.; Zhang V.; Ho P.; Sanderson J.E.

Cardiovascular mortality of patients with a restrictive filling of the mitral inflow and preserved systolic function
pp. 373-373(1)
Authors: Boccalandro F.; Loghin C.; Darwood S.; Seung-Ho K.; Barasch E.

A new noninvasive bedside hemodynamic index of early prognosis after acute myocardial infarction
pp. 373-373(1)
Authors: Messas E.; Chow C.-M.; Sagie A.; Rudski L.; Gilon D.; Levine R.A.

Incremental value of transesophageal echocardiography in prediction of thrombus/embolism in patients with atrial fibrillation undergoing cardioversion: the ACUTE clinical trial
pp. 373-373(1)
Authors: Murray R.D.; Li J.; Apperson-Hansen C.; Jasper S.E.; Grimm R.A.; Klein A.L.

Effect of atrial fibrillation on Doppler indexes of left ventricular diastolic function
pp. 373-374(2)
Authors: Brandt R.R.; Pitschner H.F.; Sperzel J.; Hamm C.W.

Early diastolic mitral annular tissue doppler velocities predicts the degree of left atrial appendage stunning following conversion to sinus rhythm after short duration atrial fibrillation in a canine model
pp. 374-374(1)
Authors: Donal E.; Yamada H.; Yong Jin Kim; Greenberg N.L.; Agler D.A.; Zhuang S.; Zhang Y.; Wallick D.W.; Mowrey K.A.; Mazgalev T.N.; Thomas J.D.; Grimm R.A.

Left atrial reservoir and active pump function after brief duration of atrial fibrillation: an acute animal study
pp. 374-374(1)
Authors: Yong Jin Kim; Yamada H.; Tabata T.; Watanabe J.; Donal E.; Agler D.A.; Zhuang S.; Zhang Y.; Wallick D.W.; Mowrey K.A.; Mazgalev T.N.; Thomas J.D.; Grimm R.A.

Is the ratio of transmitral peak E wave velocity to color flow propagation velocity useful for evaluating severity of heart failure in atrial fibrillation?
pp. 374-374(1)
Authors: Oyama R.; Murata K.; Tanaka N.; Ueda K.; Liu J.; Wada Y.; Harada N.; Hamada Y.

Comparison of cardiac three-dimensional computed tomography with transesophageal echocardiography in the evaluation of the left atrial appendage in patients with atrial fibrillation
pp. 374-374(1)
Authors: Jaber W.A.; White R.D.; Boyle J.M.; Vlassak I.; Andrea N.; Asher C.R.

Predicting 30-day cardiovascular outcomes in diabetic renal transplant recipients using dobutamine echo
pp. 374-375(2)
Authors: Giri K.S.; Freeman R.; Mehta R.H.; Rosenthal J.; Leichtman A.; Armstrong W.

Use of stress echocardiography to predict death in diabetic patients
pp. 375-375(1)
Authors: Marwick T.H.; Case C.; Sawada S.; Vasey C.; Thomas J.D.

Detection of coronary disease using dobutamine stress myocardial contrast echocardiography compared to ^99mTc-sestamibi single photon emission computed tomography
pp. 375-375(1)
Authors: Shivalkar B.; Rinkevich D.; Kaul S.; Belcik T.; Wei K.

Diabetics with positive diagnostic stress echocardiography and no history of coronary heart disease have a higher incidence of baseline wall motion abnormalities than nondiabetics
pp. 375-375(1)
Authors: Curran P.J.; Krivokapich J.

Prognostic value of dobutamine echocardiographic variables in diabetic patients
pp. 375-375(1)
Authors: Kowalski M.; Malik A.; Kukar A.; Khilnani R.; Petre L.; Yao S.-S.; Chaudhry F.A.

Atrial mechanical function and eight-week clinical outcomes in patients with atrial flutter undergoing electrical cardioversion: results from the ACUTE clinical trial
pp. 376-376(1)
Authors: Murray R.D.; Tejan-Sie S.A.; Jasper S.E.; Chung M.K.; Grimm R.A.; Apperson-Hansen C.; Lieber E.A.; Klein A.L.

Correlation of left atrial mechanical and electrical remodeling following short duration atrial fibrillation
pp. 376-376(1)
Authors: Yamada H.; Yong Jin Kim; Tabata T.; Greenberg N.L.; Donal E.; Agler D.A.; Watanabe J.; Zhang Y.; Zhuang S.; Mowrey K.A.; Mazgalev T.N.; Wallick D.W.; Van Wagoner D.R.; Thomas J.D.; Grimm R.A.

A new method for assessing left atrial systolic function during isovolumetric atrial contraction in the intact heart: an animal study
pp. 376-376(1)
Authors: Donal E.; Yamada H.; Greenberg N.L.; Agler D.A.; Zhang Z.; Zhuang S.; Wallick D.W.; Thomas J.D.; Rodriguez L.

Does maintaining normal sinus rhythm reduce left atrial size? An assessment by three-dimensional echocardiography
pp. 376-376(1)
Authors: Khankirawatana B.; Khankirawatana S.

Transesophageal echocardiography before cardioversion of atrial fibrillation: is it needed for patients receiving conventional anticoagulation but having subtherapeutic INR?
pp. 376-377(2)
Authors: Shen X.; Li H.; Rovang K.; Hee T.; Holmberg M.J.; Mohiuddin S.M.

Maintenance of sinus rhythm after cardioversion is dependent on immediate improvement of left ventricular systolic and diastolic function
pp. 377-377(1)
Authors: Harada K.; Sonoda M.; Nishimura H.; Takenaka K.; Nagai R.; Takahashi T.

The exact time course of recovery of left atrial appendage function following reversion of chronic atrial flutter to sinus rhythm
pp. 377-377(1)
Authors: Takami M.; Suzuki M.; Enjoji Y.; Inoue T.; Ikeda T.; Sugi K.; Yamaguchi T.

Stress echo in chest pain unit: the SPEED (Stress Pharmacologic Echocardiography in Emergency Department) trial
pp. 377-377(1)
Authors: Bedetti G.; Pasanisi E.; Tintori G.; Fonseca L.; Tresoldi S.; Minneci C.; Orlandini A.; Ghelarducci B.; Bugiardini R.; Picano E.

Noninvasive assessment of left anterior descending artery coronary flow reserve by transthoracic echocardiography: feasibility and results
pp. 377-377(1)
Authors: Rigo F.; Curtaia W.; Zanella C.; Nicolin P.; Della Valentina P.; Pratali L.; Palinkas A.; Raviele A.; Picano E.

Color kinetics during contrast-enhanced dobutamine stress echocardiography: its feasibility and applicability
pp. 377-378(2)
Authors: Takeuchi M.; Yoshitani H.; Miyazaki C.; Otani S.; Sakamoto K.; Yoshikawa J.; Yoshikawa J.

Risk stratification and prognosis in patients with known or suspected ischemic heart disease: a stress echocardiographic study of 1,425 patients
pp. 378-378(1)
Authors: Yao S.-S.; Kowalski M.; Malik A.; Zakir R.; Qureshi E.; Patel V.; Singh B.; Chaudhry F.A.

Noninvasive diagnosis of restenosis by transthoracic doppler echocardiography after percutaneous coronary intervention: comparison with 201-TI SPECT
pp. 378-378(1)
Authors: Hirata K.; Watanabe H.; Tokai K.; Otsuka R.; Muro T.; Teragaki M.; Yoshikawa J.

Segmental early relaxation phenomenon in stress echocardiography incidence, clinical features, and patient demographics of a distinct phenomenon: a pilot study
pp. 378-378(1)
Authors: Obeidat O.; Ananthasubramaniam K.; Alam M.; Arida M.; Al-Mallah M.

The effect of dobutamine stress on ejection and filling hemodynamics in dilated cardiomyopathy
pp. 378-378(1)
Authors: Duncan A.; O'Sullivan C.; Henein M.; Gibson D.

Histological dedifferentiation associated with functional dedifferentiation identified with dobutamine stress in a pig model of chronic ischemia
pp. 378-379(2)
Authors: Szilard M.; Liu X.; Huang Y.; Verbeken E.; Van De Werf F.; De Scheerder I.

Dobutamine stress echo may not always accurately predict segment viability in chronic global IV ischemia: an experimental study
pp. 379-379(1)
Authors: Szilard M.; Weidemann F.; Liu X.; Huang Y.; Maes A.; D'Hooge J.; Bijnens B.; Verbeken E.; Mortelmans L.; Van De Werf F.; De Scheerder I.; Sutherland G.

Reproducibility of new tissue doppler parameters, tissue tracking and strain, in normals and in patients with acute coronary syndrome
pp. 379-379(1)
Authors: Xu X.-F.; Cameiro M.; Jing Ping Sun; Coleman L.; Odabashian J.; Popovic Z.; Klein A.L.; Greenberg N.; Thomas J.D.

Contribution of myocardial abnormalities, loading, and hypertrophy to LV dysfunction in hypertensive patients: a study of ultrasound tissue characterization and strain
pp. 379-379(1)
Authors: Yuda S.; Short L.; Leano R.; Marwick T.

Assessment of systolic function in left ventricular aneurysms by strain rate imaging: studies at baseline and with alteration of function in a chronic animal model
pp. 379-380(2)
Authors: Rusk R.A.; Swanson-Birchill J.C.; Davies C.H.; Schindera S.T.; Jones M.; Kenny A.; Li X.; Sahn D.J.

Strain rate imaging or doppler myocardial imaging for the detection of regional myocardial ischemia during stress echocardiography: which method is superior?
pp. 380-380(1)
Authors: Voigt J.-U.; Exner B.; Schmiedehausen K.; Schmidt A.; Werner D.; Nixdorff U.; Flachskampf F.A.; Daniel W.G.

Regional myocardial strain and strain rate measurements by tissue doppler echocardiography in 100 normal volunteers
pp. 380-380(1)
Authors: Jing Ping Sun; Greenberg N.L.; Asher G.R.; Garcia M.J.; Stewart W.J.; Thomas J.D.

Angle-corrected color strain imaging and its application to quantitative assessment of regional contraction
pp. 380-380(1)
Authors: Nakatani S.; Kim J.; Hanatani A.; Yasumura Y.; Yamagishi M.; Kitakaze M.; Miyatake K.

Should both regional deformation and velocity of deformation be measured to characterize changes in myocardial deformation induced by alterations in inotropic states and heart rate?
pp. 380-381(2)
Authors: Weidemann F.; Jamal F.; Claus P.; Kowalski M.; Hatle L.; De Scheerder I.; Rademakers F.; Bijnens B.; Sutherland G.R.

Accurate detection of regional contraction using angle-corrected tissue strain and displacement imaging combined with two-dimensional tissue doppler tracking technique
pp. 381-381(1)
Authors: Abe Y.; Sasaki T.; Kanda R.

Regional myocardial velocity gradient and histologic analysis of experimentally altered myocardial energetics
pp. 381-381(1)
Authors: Anagnostopoulos P.C.; Pislaru C.; Dzeja P.; Belohlavek M.

Inverse relationship between simultaneously measured coronary calcification and bone mineral density in 12,000 patients: relationship to HDL cholesterol
pp. 381-381(1)
Authors: Patenaude A.; Friede J.; Fyfe A.I.

Increased severity of coronary atherosclerosis among asymptomatic Asian-Indians
pp. 381-381(1)
Authors: Hatwalkar A.; Patel N.; Reiss D.S.; Budoff M.J.

Determinants of the progression of coronary calcification: a multivariate analysis in 250 patients
pp. 381-382(2)
Authors: Maeffert R.; Pohle K.; Ropers D.; Regenfus M.; Kusus M.; Menendez T.; Muschiol G.; Moshage W.; Daniel W.G.; Achenbach S.

Direct comparison of electron beam tomography and dobutamine stress echocardiography for the detection of significant coronary artery disease
pp. 382-382(1)
Authors: Ropers D.; Achenbach S.; Kuefner C.; Menendez T.; Pohle K.; Giesler T.; Flachskampf F.A.; Daniel W.G.; Moshage W.; Nixdorff U.

Coronary calcium predicts presence and extent but not localization of exercise-induced myocardial perfusion defects
pp. 382-382(1)
Authors: Schmermund A.; Brandt-Mainz K.; Bockisch A.; Gronemeyer D.; Seibel R.; Erbel R.

Identifying high risk asymptomatic diabetics who are candidates for screening stress SPECT
pp. 382-382(1)
Authors: Rajagopalan N.; Miller T.D.; Hodge D.O.; Frye R.L.; Gibbons R.J.

Significance of stress myocardial perfusion imaging for screening of asymptomatic patients with noninsulin-dependent diabetes mellitus
pp. 382-382(1)
Authors: Bokhari S.; Bergmann S.R.

Diagnostic accuracy of adenosine myocardial perfusion tomography in patients with a right ventricular pacemaker
pp. 383-383(1)
Authors: Chano S.M.; Keng F.Y.; Cwajg E.; Arakaki D.; He Z.-X.; Reyes G.A.; Hwang W.S.; Verani M.S.

The utility of stress myocardial perfusion imaging performed prior to electrophysiological testing
pp. 383-383(1)
Authors: Coleman K.A.; Steingart R.M.; Pollack S.; Cohen T.J.

Insulin-sensitizing thiazolidinedione improves coronary endothelial dysfunction in insulin resistance by PET measurements of myocardial blood flow
pp. 383-383(1)
Authors: Hernandez-Pampaloni M.; Quinones M.; Bulnes-Enriquez I.; Jimenez X.; Hernandez G.; De la Rosa R.; Sarnat Z.; Hsueh W.; Schelbert H.R.

Which echo/doppler index is most predictive of adverse outcome in patients with severe heart failure referred for transplantation?
pp. 383-383(1)
Authors: Zahid M.; Murali S.; Holubkov R.; Sade E.; Jacques D.; Gorcsan J.

Dependence of flow propagation velocity on cardiac size: observations from patients with dilated cardiomyopathy and hypertrophic cardiomyopathy
pp. 383-384(2)
Authors: Takeda K.; Chang S.-M.; Nagueh S.F.; Torre-Amione G.; Zoghbi W.A.

The relationship between strain rate values in orthogonal directions
pp. 384-384(1)
Authors: Hashimoto I.; Swanson-Birchill J.C.; Ichida F.; Miyawaki T.; Davies C.H.; Sahn D.J.

Assessment of echocardiographic left ventricular mass using second harmonic imaging
pp. 384-384(1)
Authors: Mansencal N.; Bordachar P.; Lakhdar R.; Raffoul H.; Diebold B.; Abergel E.

Pulmonary venous atrial systolic flow reversal velocity during ventricular systole predicts left atrial elastance: a new method for assessing left atrial systolic function in an animal model
pp. 384-384(1)
Authors: Yamada H.; Donal E.; Greenberg N.L.; Martin M.; Wallick D.W.; Zhuang S.; Zhang Y.; Mazgalev T.N.; Thomas J.D.; Rodriguez L.

Changes of mitral regurgitation severity under altered loading conditions and its relationship to pulmonary venous flow
pp. 384-384(1)
Authors: Yang H.; Jones M.; Shiota T.; Jian Xin Qin; Yong Jin Kim; Daugherty D.W.; Popovic Z.; Greenberg N.L.; Pu M.; Cardon L.A.; Zetts A.D.; Thomas J.D.

Effect of intravenous microbubbles and transthoracic ultrasound on recanalization rates, myocardial blood flow, and eventual regional function following acute coronary occlusion
pp. 384-385(2)
Authors: Porter T.R.; Lof J.; Xie F.

Early detection of coronary microvascular endothelial dysfunction using intravenous myocardial contrast echocardiography
pp. 385-385(1)
Authors: Huang X.; Liu Y.; Wu P.; Zha D.; Luo Y.; Chen X.

A novel method for estimating a normalized value of myocardial blood volume by compensating for the attenuation of incident ultrasound in contrast echocardiography
pp. 385-385(1)
Authors: Yamada S.; Komuro K.; Mikami T.; Nishihara K.; Onozuka H.; Kitabatake A.

Nicorandil preserves collateral circulation even at low systemic pressure in comparison with nitroglycerin: real-time myocardial contrast echocardiographic study
pp. 385-385(1)
Authors: Iwata A.; Ishikura F.; Ohtani K.; Okazaki J.; Hirayama H.; Kashiwagi Y.; Yagura S.; Toshida T.; Asanuma T.; Beppu S.

Accuracy of intravenous myocardial contrast echocardiography for assessment of ischemic area of the heart in mice
pp. 385-385(1)
Authors: Hirayama H.; Kitamura K.; Ohtani K.; Okazaki J.; Kashiwagi Y.; Yagura S.; Toshida T.; Iwata A.; Asanuma T.; Ishikura F.; Beppu S.

Real-time myocardial contrast echocardiography reveals microvessel recruitment soon after coronary occlusion
pp. 385-386(2)
Authors: Ishikura F.; Ohtani K.; Hirayama H.; Okazaki J.; Kashiwagi Y.; Yagura S.; Toshida T.; Iwata A.; Kayano H.; Asanuma T.; Beppu S.

Automated quantification of regional myocardial perfusion by analysis of contrast-enhanced echocardiographic images
pp. 386-386(1)
Authors: Caiani E.G.; Lang R.M.; Caslini S.; Korcarz C.E.; Collins K.A.; Mor-Avi V.

A novel method to noninvasively assess effective flow areas for pediatric aortic stenosis using contrast echocardiography coupled with second harmonic imaging: comparison with the doppler continuity equation and laser flow visualization
pp. 386-386(1)
Authors: Ge S.; Shandas R.; Mazzaro L.; DeGroff C.; Knudson O.; Valdes-Cruz L.

Validation study of a new 3-D computation of flow convergence region using multithreshold velocity: an in vitro study using a dynamically changing orifice mimicking mitral regurgitation
pp. 386-386(1)
Authors: Li X.; Li X.-N.; Ha D.; Wanitkun S.; Rosenthal A.J.; Hicks S.E.; Sahn D.J.

A study of pulmonary veins: comparison of intracardiac echocardiograph with other imaging modalities and postmortem data
pp. 386-387(2)
Authors: Martin R.; Ellenbogen K.A.; Wood M.A.; Shepard R.K.; Clemo S.H.; Nixon I.

Measurement of scatterer density using high frequency intracardiac ultrasound discriminates normal from reperfused infarcted myocardium
pp. 387-387(1)
Authors: Bruce C.J.; Hao X.; Pislaru C.; Seward J.B.; Greenleaf J.F.

Intravascular ultrasound molecular imaging of ICAM-1 and Fibrin in a Yucatan miniswine model of early and late stage atherosclerosis
pp. 387-387(1)
Authors: Hamilton A.J.; Huang S.; Rabbat M.; Warnick D.; Nagaraj A.; Kane B.J.; Klegerman M.E.; MacDonald R.C.; McPherson D.D.

Is postsystolic contraction a marker of viability after acute myocardial infarction? Intracardiac measurements of myocardial wall thickness versus gross histochemical staining
pp. 387-387(1)
Authors: Pislaru C.; Bruce C.J.; Seward J.B.; Greenleaf J.F.

Quantitative analysis of still-frame parametric images of left ventricular wall motion
pp. 387-387(1)
Authors: Caiani E.G.; Collins K.A.; Korcarz C.E.; Lang R.M.; Mor-Avi V.

Delineation of the physiological significance of human coronary stenoses by real-time myocardial contrast echocardiography
pp. 387-388(2)
Authors: Peltier M.; Vancraeynest D.; Pasquet A.; d'Hondt A.-M.; Melin J.; Vanoverschelde J.-L.

Reversible perfusion defects during dipyridamole myocardial contrast echocardiography for the detection of coronary artery disease: a multicenter study
pp. 388-388(1)
Authors: Senior R.; Lepper W.; Pasquet A.; Chung G.; Hoffman R.; Vanoverschelde J.-L.; Kaul S.

Collateral flow can prevent myocardial necrosis despite persistent coronary occlusion: insights using myocardial contrast echocardiography in patients
pp. 388-388(1)
Authors: Lepper W.; Balcells E.; Lindner J.R.; Kaul S.; Belcik T.; Powers E.; Wei K.

Incremental value of intravenous myocardial contrast echocardiography in the prediction of contractile recovery and left ventricular remodeling early after acute myocardial infarction
pp. 388-388(1)
Authors: Mengozzi G.; Rossini R.; Palagi C.; Musumeci G.; Garritano L.; Molfesa M.; Petronio A.S.; Volterrani D.; Di Bello V.; Mariani M.

Microcirculation recovery after primary coronary angioplasty in patients with acute myocardial infarction treated with abciximab or intracoronary adenosina
pp. 388-388(1)
Authors: Petronio A.S.; Musumeci G.; Nardi C.; Limbruno U.; Amoroso G.; Baglini R.; Palagi C.; Marlani M.

Quantitative analysis of microcirculation of finger by intravenous contrast echo in patients with diabetes mellitus
pp. 389-389(1)
Authors: Uno K.; Takenaka K.; Sakurai S.; Asakawa M.; Kikuchi A.; Matsuzaki M.; Takahashi T.; Nakahara K.; Nagai R.

Noninvasive analysis of the remodeling process in coronary artery disease by magnetic resonance imaging
pp. 389-389(1)
Authors: Bertini P.J.; Parga J.; Chagas A.C.; Rochite C.E.; Avila L.F.; Favarato D.; da Luz P.L.

Lipid coated SPIO; introducing a novel tracer for MR imaging of macrophage infiltration in vulnerable atheroaclerotic plaque
pp. 389-389(1)
Authors: Azadpour M.; Jagannath C.; Chan D.; Cornelius N.; Casscells W.; Willerson J.; Naghavi M.

Contrast-enhanced MRI demonstrates acute response to vascular injury
pp. 389-389(1)
Authors: Terashima M.; de la Pena-Almaguer E.; Yang P.C.; Hu B.S.; McConnell M.V.

Magnetic resonance imaging and quantification of targeted drug delivery to vascular cells with paramagnetic perfluorocarbon nanoparticles
pp. 390-390(1)
Authors: Lanza G.M.; Abendschein D.R.; Yu X.; Winter P.M.; Scott M.J.; Fuhrhop R.W.; Scherrer D.E.; Wickline S.A.

Associations of atherosclerotic risk factors and coronary artery disease with plaques in thoracic and abdominal aorta detected by magnetic resonance imaging
pp. 390-390(1)
Authors: Momiyama Y.; Taniguchi H.; Ohmori R.; Hara A.; Arakawa K.; Kameyama N.; Nagasawa K.; Nagata M.; Nakamura H.; Ohsuzu F.

Comparison of high resolution magnetic resonance imaging, intravascular ultrasound, and digital subtraction angiography for assessment of atherosclerotic plaques in humans
pp. 390-390(1)
Authors: Rieber J.; Meissner O.; Rieger J.; Tato F.; Schiele T.; Pfeiffer K.J.; Hoffmann U.; Klauss V.

Transthoracic doppler echocardiography versus exercise 201-TI single photon emission computed tomography in physiological assessment of intermediate coronary stenosis
pp. 390-390(1)
Authors: Daimon M.; Watanabe H.; Yamagishi H.; Hirata K.; Kuwabara Y.; Komiyama N.; Komuro I.; Yoshikawa J.

The effect of aortic valve replacement on coronary flow reserve in patients with hemodynamically significant aortic stenosis and normal coronary angiogram
pp. 391-391(1)
Authors: Nemes A.; Forster T.; Csanady M.

physiological severity of total occlusion in the coronary artery detected by transthoracic doppler echocardiography at rest: diastolic reverse coronary flow versus exercise 201-TI single photon emission computed tomography
pp. 391-391(1)
Authors: Otsuka R.; Watanabe H.; Hirata K.; Tokai K.; Yamagishi H.; Muro T.; Yoshiyama M.; Yoshikawa J.

Great cardiac vein flow recorded with high frequency transthoracic doppler technique can predict myocardial viability in patients with anterior myocardial infarction
pp. 391-391(1)
Authors: Kuroda T.; Ito H.; Iwakura K.; Kawano S.; Okamura A.; Inoue Y.; Katoh A.; Asano K.; Kimura R.; Tkushima M.; Tanaka K.; Fujii K.

Clinical and echocardlographic spectrum of mitral valve and papillary muscle injury as a complication related to percutaneous transvenous mitral commissurotomy with inoue balloon catheter: experience from 6,800 patients
pp. 391-391(1)
Authors: Mohan J.C.; Sengupta P.P.; Jain V.; Arora R.; Nesser J.; Pandian N.G.

Comparison of proximal isovelocity surface area method with pressure half time method for evaluation of mitral valve area in patients undergoing balloon mitral valvuloplasty
pp. 391-391(1)
Authors: Roy T.N.S.; Cherian K.; Vinayakumar D.; Sajeev C.G.; Johnson F.; Velayudhan C.C.; Venugopal K.; Krishnan M.N.

Serial assessment of coronary flow velocity pattern in patients with first acute myocardial infarction: comparison to intravenous myocardial contrast echocardiography
pp. 392-392(1)
Authors: Lepper W.; Sieswerda G.T.; Franke A.; Kamp O.; de Cock C.C.; Schwarz E.R.; Voci P.; Visser C.A.; Hanrath P.; Hoffmann R.

Myocardial contrast echocardiography and multislice three-dimensional computed tomography to evaluate transmural microvascular perfusion in reperfused acute anterior myocardial infarction
pp. 392-392(1)
Authors: Wada H.; Yasu T.; Kobayashi Y.; Hujil M.; Kotsuka H.; Kubo N.; Kobayashi N.; Hashimoto S.; Tsuruya Y.; Saito M.

High potential of low dose dipyridamole stress myocardial contrast echo to detect coronary stenosis: simultaneous comparison with stress 2-D echo and ECG
pp. 392-392(1)
Authors: Katoh A.; Ito H.; Iwakura K.; Kimura R.; Tanaka K.; Ikushima M.; Okamura A.; Kawano S.; Fujii K.

Is quantification of myocardial blood flow necessary to delineate resting perfusion abnormalities in patients with prior myocardial infarction?
pp. 392-392(1)
Authors: Peltier M.; Pasquet A.; Vancraeynest D.; d'Hondt A.-M.; Ay T.; Melin J.; Vanoverschelde J.-L.

Efficacy of Sonovue, a new second generation echocontrast agent, for the evaluation of microvascular perfusion after acute myocardial infarction by real-time perfusion imaging: comparison with SPECT
pp. 393-393(1)
Authors: Agati L.; Funaro S.; Madonna M.P.; Bokor D.; Bona M.; Veneroso G.; De Maio F.

Quantitative and qualitative analysis of real-time myocardial contrast echocardiography in the detection of coronary artery stenosis
pp. 393-393(1)
Authors: Rim S.-J.; Kim H.-J.; Ahn J.-a.; Cho D.-K.; Kang S.-M.; Choi D.; Jang Y.; Cho S.-Y.; Chung N.

Does gated 18-F-fluorodeoxyglucose positron emission tomography accurately define cardiac function and better characterize myocardial tissue?
pp. 393-393(1)
Authors: Saab G.; de Kemp R.A.; Ukkonen H.; Ruddy T.D.; Beanlands R.S.

Gated rubidium-82 cardiac PET imaging: evaluation of left ventricular wall motion
pp. 393-393(1)
Authors: Machac J.; Mosci K.; Almeida O.D.; Andrews P.; Croft L.; Diamond J.A.; Henzlova M.J.; Kim C.K.; Kim M.; Krynyckyi B.R.; Sharma S.

ECG-gated F-18 FDG and Tc-99m MIBI dual-isotope simultaneous acquisition SPECT to assess myocardial glucose metabolism, perfusion, and function in a single study
pp. 393-394(2)
Authors: Matsunari I.; Kanayama S.; Fujino S.; Yoneyama T.; Taki J.; Nakajima K.; Takekoshi N.; Nekolla S.G.; Tonami N.; Hisada K.

Accuracy of gated perfusion single-photon emission tomography for left ventricular ejection fraction assessment in the presence of large perfusion defects: correlation with cardiac magnetic resonance
pp. 394-394(1)
Authors: Chen K.; Tan R.-S.; Keng F.; Cheah F.-K.; Tan K.-P.; Tan B.-S.; Lim Y.-L.; Chua T.

Does ECG-gated SPECT provide accurate measurement of left ventricular ejection fraction and volumes? A meta-analysis
pp. 394-394(1)
Authors: Ioannidis J.P.; Trikalinos T.A.; Danias P.G.

Prone imaging adds significant independent diagnostic accuracy to supine SPECT perfusion images and is superior to the contribution of wall motion
pp. 394-394(1)
Authors: Tom W.W.; Botvinick E.H.

Accuracy of dynamic SPECT acquisition for Tc-99m teboroxime myocardial perfusion imaging: preliminary results
pp. 394-394(1)
Authors: Garcia E.V.; Galt J.R.; Folks R.D.; Santana C.A.; Cullom J.; Case J.A.; Bateman T.M.

A simple technique to reduce scatter in myocardial perfusion imaging
pp. 394-395(2)
Authors: Iqbal S.; Gorski R.; Khalil M.; Lone B.; Blum S.; Heller E.N.

Multi-threshold flow 3-D color doppler reconstruction of velocity of the flow acceleration region for quantification of mitral regurgitation: a chronic animal model study
pp. 395-395(1)
Authors: Li X.; Jones M.; Li X.-N.; Zetts A.D.; Rusk R.A.; Mori Y.; Davies C.H.; Mack G.K.; Sahn D.J.

Geometric differences of mitral valvular apparatus between ischemic and dilated cardiomyopathy with significant mitral regurgitation: real-time three-dimensional echocardiography study
pp. 395-395(1)
Authors: Kwan J.; Shiota T.; Gillinov A.M.; Agler D.A.; Jian Xin Qin; Yong Jin Kim; Thomas J.D.

Detection of proximal functional occlusion of three major coronary arteries by contrast-enhanced transesophageal doppler echocardiography
pp. 395-395(1)
Authors: Nishino M.; Hoshida S.; Suna S.; Taniike M.; Egami Y.; Takeda T.; Shutta R.; Kawabata M.; Tanahashi H.; Tanouchi J.; Yamada Y.

Spatio-temporal brushlet denoising improves real time three-dimensional calculation of right ventricular function in primary pulmonary hypertension patients
pp. 395-396(2)
Authors: Gersony D.R.; Angelini E.D.; Donis J.; Dimayuga C.; Barst R.J.; Saouaf R.; Di Tullio M.R.; Laine A.F.; Homma S.

Induction of angiogenesis in a canine model of chronic myocardial ischemia with intravenous infusion of Vascular Endothelial Growth Factor (VEGF) combined with ultrasound energy and echo contrast agent
pp. 396-396(1)
Authors: Zhou Z.; Mukherjee D.; Wang K.; Zhou X.; Tarakji K.; Ellis K.; Chan A.W.; Penn M.S.; Ostensen J.; Thomas J.D.; Garcia M.; Topol E.J.; Ellis S.G.

Novel acoustic azithromycin-encapsulated liposomes inhibit Chlamydial growth in endothelial cells
pp. 396-396(1)
Authors: Tiukinhoy S.D.; Khan A.; Huang S.; MacDonald R.C.; McPherson D.D.

Effect of unfocused transcranial low frequency ultrasound and perfluorocarbon microbubbles on dissolving multiple intracranial thrombi
pp. 396-396(1)
Authors: Tessendorf T.; Xie F.; Fayad P.; Porter T.R.

Echocardiographic detection and quantification of early left ventricular hypertrophy after aortic banding in mice
pp. 396-396(1)
Authors: Wu J.C.; Ichinose F.; Bloch K.D.; Picard M.H.; Scherrer-Crosbie M.

Use of a blood substitute to determine instantaneous murine right ventricular thickening with optical coherence tomography
pp. 397-397(1)
Authors: Feldman M.D.; Villard J.W.; Kim J.; Milner T.E.; Freeman G.L.

Three-dimensional reconstruction of coronary arteriole plexus image by contrast echocardiography using high frequency transducer
pp. 397-397(1)
Authors: Ishikura F.; Ose S.; Kashiwagi Y.; Yagura S.; Ohtani K.; Okazaki J.; Hirayama H.; Asanuma T.; Iwata A.; Toshida T.; Kawagishi T.; Mine Y.; Beppu S.

Quantitative evaluation of severity of left ventricular myocardial abnormalities in Kawasaki disease: the tissue characterization study
pp. 398-398(1)
Authors: Himeno W.; Ishii M.; Sugahara Y.; Kato H.

Ultrasonic myocardial tissue characterization in normal and abnormal right ventricle
pp. 398-398(1)
Authors: Calabro P.; Pacileo G.; Limongelli G.; Russo M.G.; Scognamiglio G.; Di Salvo G.; Calvanese R.; Calabro R.

Right ventricular doppler myocardial performance index in adults with repaired tetralogy of fallot: correlations with ventricular volume indices assessed by cardiac magnetic resonance
pp. 398-398(1)
Authors: Frogoudaki A.A.; Davlouros P.A.; Li W.; Kilner P.J.; Swan L.; Pennell D.J.; Gatzoulis M.A.

An ultrasound tissue characterization study in coronary artery wall in patients with atypical Kawasaki disease
pp. 398-398(1)
Authors: Furui J.; Ishii M.; Kato H.

Effect of altered preload on left ventricular myocardial performance index
pp. 398-398(1)
Authors: Eapen R.S.; Nihill M.R.; Eidem B.W.

Predictive ability of color M-mode and doppler tissue imaging compared to traditional measures of diastolic dysfunction in children
pp. 399-399(1)
Authors: Younoszai A.K.; Garcia M.; Murphy D.

Digital 3-D velocity reconstructions allow extraction of the vena contracta (VC) area for flow rate computation: an in vitro study using raw scanline transfer and reconstruction of 3-D data
pp. 399-399(1)
Authors: Mori Y.; Detmer P.R.; Li X.-N.; Martin R.W.; Kenny A.; Martin S.L.; Sahn D.J.

Effect of vasodilator therapy on left atrioventricular valve regurgitation after atrioventricular septal defect repair
pp. 399-399(1)
Authors: Eapen R.S.; Ramaciotti C.; Lemier M.S.; Stromberg D.

Carvedilol for the treatment of congestive heart failure in children with cardiomyopathy
pp. 399-399(1)
Authors: Rusconi P.; Redha E.; Marin J.R.; Rossique-Gonzalez M.; Young M.-L.; Wolff G.S.

A medical strategy to address persistent chest tube drainage after the fontan operation
pp. 399-400(2)
Authors: Cava J.R.; Fedderly R.T.; Bevandic S.M.; Steltzer M.; Phelan P.J.; Hor K.N.; Tweddell J.S.; Litwin S.B.

The overdiagnosis of Marfan syndrome: results from a large pediatric and adult cardiovascular connective tissue disorders clinic
pp. 400-400(1)
Authors: Sparks E.A.; Daniels C.J.

Aortic regurgitation in an outlet ventricular septal defect complicated by right coronary cusp prolapse: predictors of prognosis
pp. 400-400(1)
Authors: Tomita H.; Arakaki Y.; Kurosaki K.-i.; Yagihara T.; Echigo S.

Delayed diagnosis of Kawasaki disease in the gamma globulin era: how often and why? Are the criteria too strict?
pp. 400-400(1)
Authors: Ponniah U.; Smith F.C.; Atallah-Yunes N.H.; Kavey R.-E.W.; Byrum C.J.; Kvesells D.A.; Gaum W.E.

Should we use 2-D echo to assess RV form and function in adults with repaired tetralogy of fallot?
pp. 400-400(1)
Authors: Silversides C.; Veldtman G.R.; Webb G.D.; Therrien J.; Quammie C.; Rowlins D.-M.; Merchant N.; Flynne A.; Jung M.-J.; Siu S.; McCrindle B.W.

Two thousand adults with congenital heart disease: operative and nonoperative mortality
pp. 401-401(1)
Authors: Warnes C.A.; Connolly H.M.; Puga F.J.; Danielson G.K.

How important is cardiac MRI in the management of adults with congenital heart disease?
pp. 401-401(1)
Authors: Infeld J.I.; Saouaf R.; Pearson G.; Rosenbaum M.S.

Beneficial effects of atrial septal defect percutaneous closure in asymptomatic and mildly symptomatic adults
pp. 401-401(1)
Authors: Brochu M.-C.; Baril J.-F.; Dore A.; Juneau M.; De Guise P.; Mercier L.-A.

Incidence of infective endarteritis in adults with a patent ductus arteriosus
pp. 401-401(1)
Authors: Mullen M.J.; Powell C.; McLaughlin P.R.; Webb G.

Heart transplantation in adolescents and adults with congenital heart disease
pp. 401-401(1)
Authors: Chugh R.; Marelli D.; Child J.S.; Patel B.; Perloff J.K.; Miner P.D.; Kobashigawa J.A.; George B.L.; Laks H.

Treatment of pulmonary arterial hypertension associated with congenital heart disease with intravenous epoprostenol: impact of therapy on timing of transplantation
pp. 402-402(1)
Authors: Butzel D.W.; McLaughlin V.V.; Rich S.

Sildenafil (Viagra) in childhood and neonatal pulmonary hypertension
pp. 402-402(1)
Authors: Erickson S.; Reyes J.; Bohn D.; Adatia I.

Basal pulmonary vascular resistance and its response to exogenous nitric oxide late after fontan operation
pp. 402-402(1)
Authors: Khambadkone S.; Li J.; Derrick G.; Cullen S.; Deanfield J.; de Leval M.; Redington A.

Presenting features and clinical outcomes for children with metabolic cardiomyopathies
pp. 402-402(1)
Authors: Daubeney P.E.; Nugent A.; Chondros P.; Kahler S.; Carlin J.; Weintraub R.G.

Risk factors associated with posttransplant coronary artery disease in pediatric cardiac transplant recipients
pp. 402-402(1)
Authors: Hasaniya N.; Bailey L.; Gundry S.; Razzouk A.; Chinnock R.; Checchia P.A.

Does transplantation in early infancy protect against Post-Transplant Coronary Artery Disease (PTCAD)? Evaluation by Intravascular Ultrasound (IVUS)
pp. 403-403(1)
Authors: Kuhn M.A.; Hashmi A.; Deming D.D.; Fitts J.A.; Robie S.L.; Larsen R.L.

Validation of a new echocardiographic index for the noninvasive assessment of left ventricular filling pressures in children
pp. 403-403(1)
Authors: Border W.L.; Michelfelder E.C.; Witt S.A.; Glascock B.J.; Shim D.; Spicer R.L.; Beekman R.H.; Kimball T.R.

Quantifying pulmonary regurgitation as the difference between RV and LV stroke volumes using real-time three-dimensional echocardiography: studies in a chronic animal model
pp. 403-403(1)
Authors: Rusk R.A.; Mori Y.; Irvine T.; Kenny A.; Zetts A.D.; Sachdev V.; Sahn D.J.

Integrated visualization of MRI anatomy and blood flow patterns for evaluation of aortic coarctations
pp. 403-403(1)
Authors: Parks W.J.; Brummer M.E.; Kitchen C.B.; Hong C.-Y.; Sharma S.; Fyfe D.

Pressure, velocity, and pulse wave propagation proximal and distal to a modeled adequately repaired coarctation of the aorta
pp. 404-404(1)
Authors: Young M.T.; Li X.; Schindera S.T.; Giraud G.D.; Wang H.; Burch G.H.; Nugent L.M.; Binder A.L.; Ashraf M.; Sahn D.J.

Does subaortic membrane position influence mitral valve function?
pp. 404-404(1)
Authors: Paul J.J.; Minich L.L.; Williams R.V.; Lambert L.M.; Hawkins J.A.; Tani L.Y.

Development of a new intravascular stent (Genesis Stent) for use in infants and children with congenital heart disease
pp. 404-404(1)
Authors: Forbes T.J.; Rodriguez-Cruz E.; Webster P.; Amin Z.; Benson L.; Fagan T.; Hellenbrand W.; Latson L.; Moore P.; Vincent J.; Mullins C.

Balloon angioplasty and stent placement through the side of a previously placed intravascular stent: a new option for the interventionalist
pp. 404-404(1)
Authors: Rutledge J.M.; Grifka R.G.; Bryant L.L.; Mullins C.E.; Vincent J.A.

Accuracy and reliability of intracardiac echocardiography guided device closure of atrial septal defects
pp. 405-405(1)
Authors: Mullen M.J.; Diaz B.F.; Walker F.; Sui S.C.; Benson L.; McLaughlin P.R.

Percutaneous closure of atrial septal defect under intracardiac ultrasound guidance: comparison with procedures guided by transesophageal echocardiography
pp. 405-405(1)
Authors: Garcia E.; Maroto E.; Moreno R.; Zabala I.; Diaz-Castro O.; Maroto C.; Zunzunegui J.L.; Greco R.

Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: impact of patent foramen ovale dedicated devices on procedural complications and residual shunt
pp. 405-405(1)
Authors: Schwerzmann M.; Meier B.; Wahl A.; Eberli F.R.; Seiler C.; Mehta H.; Zimmerli M.; Windecker S.

Video-assisted ligation of patent ductus arteriosus: results of multiple ligation technique, need for transesophageal echocardiography, and appropriateness of same-day hospital discharge
pp. 405-405(1)
Authors: DeCamoli W.M.; Peterson K.L.; Sanchez G.R.; Myung R.J.; Berry-LeBoeuf M.; Fabian C.; Wernovsky G.

Intraoperative transesophageal echo for repair of aortic insuffiency does not predict later aortic valve function in children
pp. 406-406(1)
Authors: Yung D.; Altmann K.; Gersony W.M.; Solowiejczyk D.E.; Quaegebeur J.M.; Printz B.F.

Hemodynamic effects of sodium nitroprusside after superior cavopulmonary connection
pp. 406-406(1)
Authors: Simsic J.M.; Bradley S.M.; Mulvihill D.M.

Impact of preoperative aortic cusp prolapse on long-term outcome after surgical closure of subarterial ventricular septal defect
pp. 406-406(1)
Authors: Cheung Y.-f.; Chiu C.S.; Yung T.-c.; Chau A.K.

Power M-mode transcranial doppler assessment of cerebral microemboli during percutaneous closure of patent foramen ovale
pp. 406-406(1)
Authors: Spencer M.P.; Moehring M.; White J.; Heidmiller C.; Gray W.; Reisman M.; Olsen J.; Krabill K.

Long-term results of apical aortic valved conduits in children with complex left ventricular outflow tract obstruction
pp. 406-406(1)
Authors: Brown J.W.; Ruzmetov M.; Vijay P.; Turrentine M.W.

Effect of reverse flow on the fluid dynamics of the Total Cavo-pulmonary Connection: a potential cause of progressive heart failure
pp. 407-407(1)
Authors: DeGroff C.G.; Orlando W.; Hertzberg J.; Shandas R.; Valdes-Cruz L.

An assessment of the major flow features that affect energy loss and potential for thrombus formation within the modified total cavo-pulmonary connection: computational and scaled in-vitro studies
pp. 407-407(1)
Authors: Shandas R.; Khunatorn Y.; DeGroff C.; Orlando W.; Mahalingam S.; Valdos-Cruz L.

Indices of diastolic right ventricular function: load-dependence and changes after chronic right ventricular pressure overload in lambs
pp. 407-407(1)
Authors: Leeuwenburgh B.P.; Steendijk P.; Helbing W.A.; Baan J.

Implantation of stents for aortic coarctation: resulting pressure gradients at rest and during exercise: studies in a pulsatile aortic in vitro model of post stent coarctation
pp. 407-407(1)
Authors: Schindera S.T.; Li X.; Giraud G.D.; Wang H.; Young M.T.; Swanson-Birchill J.C.; Ashraf M.; Burch G.H.; Kececioglu D.; Sahn D.J.

Evaluation of the accuracy of a new semiautomatic 3-D program (PMAP) by quantifying right ventricular volume using real-time 3-D imaging: studies in an in vitro model duplicating human RV anatomy
pp. 408-408(1)
Authors: Oei L.S.L.; Schindera S.T.; Li X.; Mehwald P.S.; Kuo J.; Castellucci J.; von Ramm O.T.; Kececioglu D.; Sahn D.J.

Molecular cloning and characterization of a potential candidate gene for nonsyndromic atrioventricular septal defect on 1p31-1p21
pp. 408-408(1)
Authors: Zhao Y.; Meng X.; Cao H.; Mi L.; Wei Y.; Liew C.-C.; Ding J.

Spatio-temporal description of the development of the mouse cardiac conduction system using a cGATA-6 gene enhancer marker
pp. 408-408(1)
Authors: Juraszek A.L.; Edwards A.V.; Phelps A.; Burch J.B.; Wessels A.

Shortened outflow tract leads to altered cardiac looping after neural crest ablation
pp. 408-408(1)
Authors: Yelbuz T.M.; Waldo K.L.; Kumiski D.H.; Stadt H.A.; Wolfe R.R.; Leatherbury L.; Kirby M.L.

Increased vascular endothelial growth factor in patients with cyanotic congenital heart disease may not be normalized after fontan type operation
pp. 408-409(2)
Authors: Suda K.; Matsumura M.; Miyanishi S.

Leukocyte adhesion factor Mac-1 and migration inhibitory factor-related protein (MRP) on granulocyte plays the essential role for causing vasculitis in kawasaki disease and the gamma globulin therapy inhibit leukocyte-endothelial cell adhesion
pp. 409-409(1)
Authors: Fukazawa R.; Uchikoba Y.; Kuramochi Y.; Ikegami E.; Kamisago M.; Katsube Y.; Seki T.; Ogawa S.

Termination of intraatrial reentrant tachycardia using implanted pacemakers in patients following atrial switch repair of transposition of the great arteries
pp. 409-409(1)
Authors: Serwer G.A.; Bradley D.J.; Fischbach P.S.; George K.A.; Leroy S.S.; Dick M.

Comparison of adenosine-sensitive and adenosine-resistant accessory pathways in children
pp. 409-409(1)
Authors: Bradley D.J.; Madden L.M.; Stefanelli C.B.; Saarel E.V.; Asnes J.D.; Serwer G.A.; Fischbach P.S.; Di M.

Biologic response to the HELEX&unknown; septal occluder implantation in the canine heart
pp. 409-409(1)
Authors: Lane G.K.; Macri N.P.; Rhodes J.F.; Mesia C.I.; Prieto L.R.; Sawyer P.L.; Manning M.M.; Anderson D.J.; Zahn E.M.; Latson L.A.

CardloSEAL device closure of multiple atrial septal defects with and without atrial septal aneurysm
pp. 410-410(1)
Authors: Turner D.R.; Teitel D.F.; Moore P.

The role of transcatheter therapy for treatment of pulmonary vein stenosis: acute and long-term results
pp. 410-410(1)
Authors: Alomrani A.N.; Nihill M.R.; Grifka R.G.; McMahon C.J.; Mullins C.E.; Vincent J.A.

Cost effectiveness of coarctation strategies: endovascular stent versus surgery
pp. 410-410(1)
Authors: George J.C.; Shim D.; Bucuvalas J.C.; Immerman E.; Manning P.B.; Pearl J.M.; Beekman R.H.

Stress echocardiography following the arterial switch operation for D-transposition of the great arteries
pp. 410-410(1)
Authors: Garabedian C.P.; Di Tullio M.R.; Kaufman S.; Quaegebeur J.M.; Gersony W.M.; Rosenbaum M.S.

Prospective echo diagnosis and surgical repair of anomalous origin of a coronary artery from the opposite sinus with an interarterial course
pp. 410-411(2)
Authors: Frommelt P.C.; Frommelt M.A.; Berger S.; Pelech A.N.; Tweddell J.S.

Noninvasive method for quantification of aortopulmonary collateral flow in bi-directional glenn shunts
pp. 411-411(1)
Authors: Srivastava S.; Kim C.K.; Machac J.; Sommer R.J.

The diagnostic yield of echocardiographic testing in pediatric patients with chest pain
pp. 411-411(1)
Authors: Cooper D.S.; Cripe L.H.; Glascock B.J.; Witt S.A.; Kimball T.R.

MRI evaluation of cardiac tumor characteristics in infants and children
pp. 411-411(1)
Authors: Kiaffas M.G.; Powell A.J.; Geva T.

Three-dimensional free-breathing pediatric cardiovascular magnetic resonance imaging with real-time navigator respiratory synchronization
pp. 411-411(1)
Authors: Vick G.W.; Muthupillai R.; Pignatelli R.H.; Kovalchin J.P.; Chung T.

Endovascular stent implantation in patients with stenotic aorto-arteriopathies: early and medium-term results
pp. 411-412(2)
Authors: Siwik E.S.; Lock J.E.; Perry S.B.

Transcatheter aortic valvuloplasty assisted by right ventricular pacing
pp. 412-412(1)
Authors: Ing F.F.; Boramanand N.K.; Mathewson J.; Maginot K.; Perry J.C.

Intracardiac echocardiography during interventional catheterization for congenital heart defects
pp. 412-412(1)
Authors: Rhodes J.F.; Preminger T.J.; Mesia C.I.; Lane G.K.; Prieto L.R.; Latson L.A.

Intermediate follow-up for atrial septal defect closure with the HELEX&unknown; septal occluder device: the FDA phase I feasibility trial
pp. 412-412(1)
Authors: Rhodes J.F.; Lane G.K.; Nykanen D.; Radvansky P.A.; Zahn E.M.; Latson L.A.

Amplatzer fenestration device: application in humans to maintain patency of fontan fenestration and shunt through the atrial septum
pp. 412-412(1)
Authors: Amin Z.; Danford D.A.; Pedra C.A.

Quantitative angiographic assessment of pulmonary blood flow in children with congenital heart defects
pp. 412-413(2)
Authors: Gruenstein D.H.; Beekman R.H.; Spicer R.L.

Neo-aortic root dilation and regurgitation are progressive following the arterial switch operation
pp. 413-413(1)
Authors: Marino B.S.; Wernovsky G.; Kreb D.L.; Mantel S.F.; van der Woerd W.L.; Visser D.; Meijboom E.; McElhinney D.E.; Novello R.T.; Cohen M.S.

Pulmonary atresia with ventricular septal defect: a 25-year single institution outcome study
pp. 413-413(1)
Authors: Amark K.M.; Freedom R.M.; Yoo S.-J.; MacDonald C.; Williams W.G.; McCrindle B.W.

Subjects with surgically treated complex congenital heart disease report health related quality of life equal to healthy peers
pp. 413-413(1)
Authors: Mussatto K.A.; Frisbee S.J.; Sachdeva R.C.; Pelech A.N.; Litwin S.B.; Tweddell J.S.

Outcomes and impact of a nonconfluent pulmonary artery originating from the distal end of the arterial duct in 43 patients
pp. 413-414(2)
Authors: Trivedi K.R.; McCrindle B.W.; Yoo S.-J.; Benson L.N.; Williams W.G.; Freedom R.M.

Elevated pre-operative ventricular diastolic relaxation indices correlate with poor outcome in fontan patients
pp. 414-414(1)
Authors: Syed A.U.; Border W.L.; Michelfelder E.C.; Uzark K.; Manning P.B.; Pearl J.M.

The skeletal muscle hemodynamics and endothelial dysfunction in patients after fontan procedure
pp. 414-414(1)
Authors: Inai K.; Nakazawa M.; Takeda S.; Saita Y.

Fast acquisition of 3-D volumes (14-16/sec) allows anyplane navigation for defining anatomy on fetal echocardiography as well as multiplanar 3-D motion displays
pp. 414-414(1)
Authors: Sahn C.S.; Balderston K.D.; Sahn D.J.

Left ventricular myocardial performance in the fetus with severe tricuspid valve disease
pp. 414-414(1)
Authors: Inamura N.; Smallhorn J.; Hornberger L.K.

Magnetocardiography in the detection of fetal arrhythmias
pp. 415-415(1)
Authors: Golbach E.G.; Stinstra J.G.; Petrs M.J.; Quartero R.H.; Klumper F.J.; Meijboom E.J.

Hydrops fetalis: primary cardiovascular etiologies and clinical outcome in 98 affected pregnancies
pp. 415-415(1)
Authors: Tsang W.; van der Velde M.; Windrim R.; Smallhorn J.; Hornberger L.K.

Fetal heterotaxy syndrome: spectrum of heart disease, accuracy of diagnosis, and clinical outcome
pp. 415-415(1)
Authors: Taketazu M.; Lougheed J.; Smallhorn J.F.; Yoo S.-J.; Hornberger L.K.

Cellular insights into the role of endothelin-1 in the cardiovascular pathology of twin-twin transfusion syndrome
pp. 415-415(1)
Authors: Porepa L.; Barrea C.; Singhroy S.; Hornberger L.K.

The potential role of plasma neurohormones in the follow-up of unoperated or physiologically repaired congenitally corrected transposition of the great arteries
pp. 415-415(1)
Authors: Dodge-Khatami A.; Tulevski I.I.; Bennink G.B.; Hitchcock J.F.; de Mol B.A.; van der Wall E.E.; Mulder B.J.

Arginine-vasopressin is beneficial in weaning children from cardiopulmonary bypass following open heart surgery
pp. 416-416(1)
Authors: Abraham S.S.; Berman-Rosenzweig E.; Zucker H.A.; Smerling A.J.; Quaegebeur J.M.; Starc T.J.

Glucocorticold pretreatment for congenital heart surgery improves cardiac output and reduces bypass induced cytokine and adhesion molecule expression
pp. 416-416(1)
Authors: Schroeder V.A.; Pearl J.M.; Manning P.B.; Shanley T.P.; Nelson D.P.

Glucocorticolds reduce troponin I degradation in a neonatal piglet model of cardlopulmonary bypass
pp. 416-416(1)
Authors: Schwartz S.M.; Duffy J.Y.; Nelson D.P.; Goins S.; Ferguson R.; Pearl J.M.

Long-term effect of ACE inhibitor on chronic mitral regurgitation
pp. 417-417(1)
Authors: Lee H.-Y.; Cho H.-J.; Chae I.-H.; Lee M.-M.

Effect of left ventricular size regression on mitral valve function and anatomy
pp. 417-417(1)
Authors: Noor H.; Stoletniy L.; Bansal R.C.; Pai R.G.

Loss of annular saddle shape is associated with acute ischemic mitral regurgitation
pp. 417-417(1)
Authors: Gorman J.H.; Jackson B.M.; Moainie S.L.; Guy T.S.; St. John-Sutton M.; Edmunds L.H.; Gorman R.C.

Outcome of mitral surgery in patients with coronary disease
pp. 417-417(1)
Authors: Dahlberg P.S.; Orszulak T.A.; Mullany C.J.; Enriquez-Sarano M.; Daly R.C.; Schaff H.V.

Ischemic mitral regurgitation is independent of papillary muscle dysfunction: clinical demonstration by quantitative echocardiography in patients with inferior myocardial infarction
pp. 417-418(2)
Authors: Uemura T.; Otsuji Y.; Kumanohoso T.; Yoshifuku S.; Kisanuki A.; Minagoe S.; Levine R.A.; Tei C.

End-systolic left ventricular diameter =< 45 mm in mitral regurgitation is an insensitive marker of left ventricular dysfunction and a poor predictor of postoperative outcome
pp. 418-418(1)
Authors: Enriquez-Sarano M.; Bellamy M.F.; Orszulak T.A.; Schaff H.V.

Coronary artery bypass grafting in patients with dialysis-dependent end stage renal disease: a nested case-control study
pp. 418-418(1)
Authors: Powell K.L.; Smith J.M.; Woods S.E.; Hendy M.P.

Multiple arterial grafts improved survival following coronary bypass surgery
pp. 418-418(1)
Authors: O'Keefe J.H.; Fritz K.; Jones P.

Emergent and urgent coronary surgery after attempted Percutaneous Coronary Intervention (PCI): an analysis of the NHLBI database in the era of stents
pp. 418-418(1)
Authors: Schindler J.T.; Williams D.O.; Holmes D.R.; Johnston J.; Detre K.M.; Cohen H.A.

Lipoproteins, lipid peroxides, and soluble selectin in patients undergoing redo coronary artery bypass surgery
pp. 419-419(1)
Authors: Jovin I.S.; Taborski U.; Jovin A.; Schonburg M.; Ricken W.W.; Schreiner K.; Kupfermann U.; Winckler K.; Klovekorn W.-P.; Muller-Berghaus G.

Bosentan: a therapeutic strategy for severe radial artery vasospasm
pp. 419-419(1)
Authors: Verma S.; Hyder T.; Ko L.; Badiwala M.V.; Fedak P.; Li R.-K.; Weisel R.D.; Rao V.; Fremes S.E.

Can cardiac operations be performed safely in liver transplant recipients?
pp. 419-419(1)
Authors: Burkhart H.M.; Mullany C.J.; Kamath P.S.; Daly R.C.; Dearani J.A.; Orszulak T.A.; Schaff H.V.; Zehr K.J.

LV remodeling following aortic valve replacement for aortic stenosis in the elderly
pp. 419-419(1)
Authors: Aurigemma G.P.; Sweeney-Walsh A.; Lancey R.; Ronen A.; Tighe D.A.; Meyer T.E.

The rate of hemodynamic progression is strongly predictive of clinical outcome mostly in mild and moderate aortic stenosis
pp. 419-420(2)
Authors: Antonini-Canterin F.; Erlicher A.; Cervesato E.; Piazza R.; Faggiano P.; Gualeni A.; Romeo C.; Pavan D.; Nicolosi G.

Can instantaneous changes in aortic valve area during ejection predict valve area response to dobutamine testing in valvular aortic stenosis?
pp. 420-420(1)
Authors: Burwash I.G.; Beauchesne L.M.; Hay K.M.; Chan K.-L.

Left ventricular longitudinal shortening in patients with aortic stenosis: relationship with symptomatic status
pp. 420-420(1)
Authors: Tongue A.; Pibarot P.; Dumesnil J.G.; Laforest I.; Theriault C.; Durand L.-G.

Effect of jet eccentricity on functional severity of congenital aortic stenosis
pp. 420-420(1)
Authors: Richards K.E.; Deserranno D.; Greenberg N.L.; Thomas J.D.; Garcia M.J.

Effect of aortic and outflow track anatomy in aortic stenosis hemodynamics
pp. 420-420(1)
Authors: Deserranno D.; Richards K.E.; Greenberg N.L.; Thomas J.D.; Garcia M.J.

Mechanisms of mitral regurgitation in aortic stenosis: lack of relationship to aortic stenosis severity and management implications
pp. 421-421(1)
Authors: Pai R.G.; Varadarajan P.

Is aortic valve sclerosis a manifestation of atherosclerosis?
pp. 421-421(1)
Authors: Heggunje P.S.; Pratap T.; Mukherjee R.; Wade M.J.; Shah J.S.; Kelly P.; Khan N.

Aortic valve sclerosis, hemodynamics, and cardiovascular risk in hypertension: a LIFE substudy
pp. 421-421(1)
Authors: Olsen M.H.; Wachtell K.; Bella J.N.; Palmieri V.; Gerdts E.; Nieminen M.S.; Smith G.; Dahlof B.; Ibsen H.; Devereux R.B.

Exercise testing predicts symptom onset in aortic stenosis: a prospective study of 85 patients
pp. 421-421(1)
Authors: Das P.; Rimington H.; Takeda S.; Crowther A.; Chambers J.

Increased incidence of surgical reexploration for postoperative bleeding due to early postoperative use of unfractionated heparin or enoxaparin
pp. 421-421(1)
Authors: Jones H.U.; Muhlestein J.B.; Jones K.W.; Renlund D.G.; Bair T.L.; Home B.D.; Lappe D.L.; Doty D.B.

Combination of aspirin and clopidogrel exerts superior antithrombotic potency compared to warfarin on mechanical heart valves in a rabbit flow chamber
pp. 422-422(1)
Authors: Schlitt A.; Hauroeder B.; Buerke M.; Bickel C.; Peetz D.; Campbell A.; Hundt F.; Meyer J.; Rupprecht H.J.

Role of serial troponin testing for diagnosis of perioperative myocardial infarction after cardiac surgery
pp. 422-422(1)
Authors: Lehrke S.; Giannitsis E.; Muller-Bardorff M.; Steen H.; Opitz A.; Peters H.; Wiegand U.K.H.; Katus H.A.